Seite drucken Seite drucken

Home  >  Publikationen

Publikationen

Die folgenden Publikationen sind nach Jahren und alphabetisch gelistet. Ferner finden Sie die Abstracts des Kompetenznetzes HIV/AIDS hier aufgeführt.

Falls Sie eine Veröffentlichung mit Beteiligung des Kompetenznetzes HIV/AIDS submittieren möchten, bitten wir Sie, die Publikationsrichtlinien des Kompetenznetzes HIV/AIDS zu beachten.


 

Übersicht

Kohorten- und Biomaterialbank-Publikationen

Publikationen basierend auf der KompNet Kohorte und Biomaterialbank

2012

  ·        Liptrott N., Pushpakom S., Wyen C., Fätkenheuer G., Hoffmann C., Mauss S., Knechten H., Brockmeyer N.H., Hopper-Borge E., Back D., Khoo S., Pirmohamed M., Owen A.  Association of ABCC10 polymorphisms with nevirapine plasma concentrations in the German Competence Network for HIV/AIDS. on behalf of the German Competence Network for HIV/AIDS. Pharmacogenet Genomics. 2011 Nov 11. [Epub ahead of print]

  ·        Reinsch N., Neuhaus K., Esser S., Potthoff A., Hower M., Mostardt S., Neumann A., Brockmeyer N.H., Gelbrich G., Erbel R. & Neumann T. Are HIV patients undertreated? Cardiovascular risk factors in HIV: results of the HIV-HEART study. German Competence Network Heart Failure; German Competence Network for HIV/AIDS. . Eur J Prev Cardiol. 2012 Apr;19(2):267-74. Epub 2011 Feb 28.

 

2011

·       Gelbrich B, Neumann T, Esser S, Potthoff A, Reinsch N, Hower M, Dannhauer KH, Loeffler M, Brockmeyer NH, Erbel R, Gelbrich G; HIV-HEARTStudy Investigative Group, Competence Networks HeartFailure and HIV/AIDS.Oral health and the heart – Does HIV infection open a pathophysiological gateway? Int J Cardiol. 2011;151(2):254-7. (Letter to the editor) [KompNet cohort data]

·       Judd et al. The Pursuing Later Treatment Options II (PLATO II) Project Team of COHERE. Risk of triple class virologic failure in HIVinfected children. Lancet. 2011, 7;377(9777):1580-7. [KompNet cohort data]

·       Liptrott NJ, Pushpakom S, Wyen C, Fätkenheuer G, Hoffmann C, Mauss S, Knechten H, Brockmeyer NH, Hopper-Borge E, Siccardi M, Back DJ, Khoo SH, Pirmohamed M, Owen A; on behalf of the German Competence Network for HIVAIDS. Association of ABCC10 polymorphisms with nevirapine plasma concentrations in the German Competence Network for HIV/AIDS. Pharmacogenet Genomics. 2011 Nov 11. [Epub ahead of print] [KompNet cohort data and materialbank]

·       Mueller S.M., Spriewald B.M., Bergmann S., Eismann K., Leykauf M., Korn K., Walter H., Schmidt B, Arnold M.L., Harrer E.G., Kaiser R, Schweizer F, Braun P, Reuter S, Jaeger H, Wolf E, Brockmeyer N.H, Jansen K, Michalik C, Harrer T and the German Competence Network for HIV/AIDS. Influence of Major HIV-1 Protease Inhibitor Resistance Mutations on CTL Recognition. JAIDS, 2011;56(2):109-17. (IF 4.570) [KompNet cohort data and materialbank]

·       Plettenberg A, Brockmeyer N H, Haastert B, Michalik C, Dupke S, Schewe K, Rausch M, Hower M, Ulmer A, Jäger H, Arendt G, Jansen K and the Competence Network for HIV/AIDS. Impact of earlier HAART initiation on immune status and clinical course of treated patients on basis of cohort data of the German Competence Network for HIV/AIDS, Infection, 2011;39(1):3-12. (IF 2.051) [KompNet cohort data]

·       Schipani A, Wyen C, Mahungu T, Hendra H, Egan D, Siccardi M, Davies G, Khoo S, Fätkenheuer G, Youle M, Rockstroh J, Brockmeyer NH, Johnson MA, Owen A, Back DJ; German Competence Network for HIV/AIDS. Integration of population pharmacokinetics and pharmacogenetics: an aid to optimal nevirapine dose selection in HIV-infected individuals. J Antimicrob Chemother. 2011;66(6):1332-9. [KompNet cohort data and materialbank]

·       Wyen C et al. on behalf of the German Competence Network for HIV/AIDS. Cytochrome P450 2B6 (CYP2B6) and constitutive androstane receptor (CAR) polymorphisms are associated with early discontinuation of efavirenz-containing regimens. J Antimicrob Chemother. 2011;66(9):2092-8. [KompNet cohort data and materialbank]

 

2010

·       Brockmeyer NH, Okamoto T. Abstracts of the 5th German-Japanese HIV-Symposium, Eur J Med Res 2010, 15(8): 323-37. (IF 1.130) [i.a. KompNet cohort data]

·      Kreuter A, Potthoff A, Brockmeyer NH, Gambichler T, Swoboda J, Stücker M, Schmitt M, Pfister H, Wieland U. German Competence Network HIV/AIDS. Anal carcinoma in HIV-positive men: results of a prospective study from Germany. Br J Dermatol. 2010 Feb 22. (IF 4.260) [Epub ahead of print] [KompNet cohort data and materialbank]

·       Mueller S.M., Spriewald B.M., Bergmann S., Eismann K., Leykauf M., Korn K., Walter H., Schmidt B, Arnold M.L., Harrer E.G., Kaiser R, Schweizer F, Braun P, Reuter S, Jaeger H, Wolf E, Brockmeyer N.H, Jansen K, Michalik C, Harrer T and the German Competence Network for HIV/AIDS. Influence of Major HIV-1 Protease Inhibitor Resistance Mutations on CTL Recognition. JAIDS, 2010 Nov 24. Epub ahead of print. (IF 4.570) [KompNet cohort data and materialbank]

·       Potthoff A, Brockmeyer NH, Gelbrich G, Neuhaus K, Esser S, Reinsch N, Hower M, Mostardt S, Neumann A, Neumann T; Competence Center Cardiac Insufficiency and the Competence Network HIV/AIDS. Lipodystrophy – a sign for metabolic syndrome in patients of the HIV-HEART Study. J Dtsch Dermatol Ges. 2010 Feb;8(2):92-8. (IF 1.403) [KompNet cohort data]

·       Reinsch N, Neuhaus K, Esser S, Potthoff A, Hower M, Brockmeyer NH, Erbel R, Neumann T; German Competence Network for Heart Failure; German Competence Network for HIV AIDS. Prevalence of cardiac diastolic dysfunction in HIV-infected patients: results of the HIV-HEART study. HIV Clin Trials. 2010 ;11(3):156-62. (IF 1.626) [KompNet cohort data]

·       Reinsch N, Esser S, Sundermeyer  A, Neuhaus K, Brockmeyer  N, Potthoff A, Erbel R, Buck T, Neumann T for the HIV-HEART Study Investigative Group supported by the German Heart Failure Network and the Competence Network for HIV/AIDS. Echocardiographic findings in HIV-infected patients: Results from a large, prospective, multicenter HIV-Heart Study. HIV med 2010. In press. (IF 2.878) [KompNet cohort data]

·       Study Group on Death Rates at High CD4 Count in Antiretroviral Naive Patients, Lodwick RK, Sabin CA, Porter K, Ledergerber B, van Sighem A, Cozzi-Lepri A, Khaykin P, Mocroft A, Jacobson L, De Wit S, Obel N, Castagna A, Wasmuth JC, Gill J, Klein MB, Gange S, Riera M, Mussini C, Gutiérrez F, Touloumi G, Carrieri P, Guest JL, Brockmeyer NH, Phillips AN. Death rates in HIV-positive antiretroviral-naive patients with CD4 count greater than 350 cells per µL in Europe and North America: a pooled cohort observational study. Lancet. 2010 Jul 31;376(9738):340-5. (IF 30.758) [KompNet cohort data]

 

2009

·         Brockmeyer NH, Okamoto T. 4th German-Japanese HIV-Symposium, 23rd-24th March 2009, Eur J Med Res 2009, 14(8): 332-44. (IF 1.130) [i.a.KompNet cohort data]

·         Jansen K., N. H. Brockmeyer, M. Hahn, I. Kaul, S. Fenske, M. Rausch, B. Kuhlmann, A. Ulmer, E. Lauenroth-Mai, T. Harrer, M. Hower, A. Skaletz-Rorowski, C. Michalik, and the Competence Network for HIV/AIDS. Epidemiological composition, clinical and Treatment Characteristics for the patient cohort of the German Competence Network for HIV/AIDS. Eur J Med Res (2009) 14: 415-25. (IF 1.130) [KompNet cohort data]

·         Jansen K, Michalik C, Hahn M, Dupke S, Esser S, Jaeger H, Köppe S, Moll A, Plettenberg A, Schmidt RE, Skaletz-Rorowski A, Brockmeyer NH, and the Competence Network for HIV/AIDS. The Patient Cohort of the German Competence Network for HIV/AIDS (KompNet): a Profile. Eur J Med Res. (2009) 14: 323-331. (IF 1.130) [KompNet cohort data]

·         Kremer H, Sonnenberg-Schwan U, Arendt G, Brockmeyer NH, Potthoff A, Ulmer A, Graefe K, Lorenzen T, Starke W, Walker UA; German Competence Network HIV/AIDS. HIV or HIV-therapy? Causal attributions of symptoms and their impact on treatment decisions among women and men with HIV. All Around Women Special, German AIDS Society, Eur J Med Res. 2009 Apr 16;14(4):139-46. (IF 1.130) [KompNet cohort data]

·         Neumann T, Reinsch N, Neuhaus K, Brockmeyer N. H., Potthoff A, Esser S, Hower M, Neumann A, Mostardt S, Gelbrich G, Erbel R, für die HIV-HEART Studie on behalf of the German Competence Network of Heart Failure and the German Competence Network for HIV/AIDS. Wertigkeit des Biomarkers BNP bei HIV-infizierten Patienten BNP in HIV-infected Patients. Herz Vol. 34, No. 8., 1.12.2009, pp. 634-640. (IF 0.890)  [KompNet cohort data]

·         Nolting T, Lindecke A, Koutsilieri E, Maschke M, Husstedt IW, Sopper S, Stüve O, Hartung HP, Arendt G., Competence Network HIV/AIDS. Measurement of soluble inflammatory mediators in cerebrospinal fluid of human immunodeficiency virus-positive patients at distinct stages of infection by solid-phase protein array. J Neurovirol. 2009 Dec;15(5-6):390-400. (IF 2.336) [KompNet materialbank]

·         Obermann M, Küper M, Kastrup O, Yaldizli O, Esser S, Thiermann J, Koutsilieri E, Arendt G, Diener HC, Maschke M; for the German Competence Network HIV/AIDS. Substantia nigra hyperechogenicity and CSF dopamine depletion in HIV. Journal of Neurology; 2009;256(6):948-53. (IF 2.536) [KompNet materialbank]

·        Reinsch N., Neuhaus K., Krings P., Hower M., Becker-Boost I., Esser S., Potthoff A., Brockmeyer N.H., Erbel R, Neumann T, 1 on behalf of the German Heart failure Network and the German HIV/ AIDS Network. Prevalence and risc factors of prolonged QTc interval in HIV-infected patients: Results of the HIV-HEART-Study. HIV Clin Trials. 2009 Jul-Aug;10(4):261-8. (IF 1.626) [KompNet cohort data]

 

2008

·         Cagigi A, Mowafi F, Phuong Dang L, Tenner-Racz K, Atlas A, Grutzmeier S, Racz P, Chiodi F, Nilsson A. Altered expression of the receptor-ligand pair CXCR5/CXCL13 in B cells during chronic HIV-1 infection. Blood, VOL.: 112: 4401-4410, 2008. [KompNet materialbank]

·         Kreuter A., Brockmeyer N.H., Weissenborn S.J., Gambichler T., Stuecker M., Altmeyer P., Pfister H., Wieland U., for the German Competence Network HIV/AIDS. Penile Intraepithelial Neoplasia Is Frequent in HIV-Positive Men with Anal Dysplasia. J Invest Dermatol. 2008 Sep;128(9):2316-24. (IF 2.085) [KompNet materialbank]

·         Kreuter A; Potthoff A; Brockmeyer NH; Gambichler T; Stücker M; Altmeyer P; Swoboda J; Pfister H; Wieland U. Imiquimod leads to a decrease of human papillomavirus DNA and to a sustained clearance of anal intraepithelial neoplasia in HIVinfected men. J Invest Dermatol ; 128(8):2078-83; 2008. (2.085) [KompNet cohort data]

·         Schulbin H, Bode H, Stocker H, Schmidt W, Zippel T, Loddenkemper C, Engelmann E, Epple HJ, Arastéh K, Zeitz M, Ullrich R; Kompetenznetz HIV/AIDS Germany. Cytokine expression in the colonic mucosa of human immunodeficiency virus-infected individuals before and during 9 months of antiretroviral therapy. J Antimicrob Chemother. 2008 Sep;52(9):3377-84. Epub 2008 Jun 23. (IF 4.802) [KompNet materialbank]

·         Wyen C., Hendra H., Vogel M., Hoffmann C., Knechten H., Brockmeyer N.H., Bogner J.R., Rockstroh J., Esser S., Jaeger H., Harrer T., Mauss S., van Lunzen J., Skoetz N., Jetter A., Groneuer C., Fätkenheuer G., Khoo S. H., Egan D., Back D.J., Owern A., German Competence Network for HIV/AIDS. Impact of CYP2B6 983T>C polymorphism on non-nucleoside reverse transcriptase inhibitor plasma concentrations in HIV-infected patient. J Antimicrob Chemother.; 61(4):914-8, 2008. (IF 4.802) [KompNet cohort data and amterialbank]

 

2007

·         Breuckmann F; Nassenstein K; Kondratieva J; Esser S; Erbel R; Potthoff A; Brockmeyer NH; Neumann T; Barkhausen J; German Heart Failure Network; Competence Network HIV/AIDS. Characterization of cardiac abnormalities in HIV+ individuals with increased BNP levels. Eur J Med Res; VOL: 12(5): 185-190,2007. (IF 1.040)  [KompNet cohort data]

·         Cepok S; von Geldern G; Nolting T; Grummel V; Srivastava R; Zhou D; Hartung HP; Adams O; Arendt G; Hemmer B. Viral load determines the B-cell response in the cerebrospinal fluid during human immunodeficiency virus infection. Annals of neurology; VOL: 62(5): 458-67, 2007. [KompNet materialbank]

·         Kreuter A; Brockmeyer NH; Altmeyer P; Pfister H; Wieland U; German Competence Network HIV/AIDS. Rapid onset of multifocal HPV72-associated oral intraepithelial neoplasia in a HIVinfected patient. British Journal of Dermatology; VOL: 157; 826-8, 2007. [KompNet materialbank]

·         Kreuter A; Wieland U; Gambichler T; Altmeyer P; Pfister H; Tenner-Racz K; Racz P; Potthoff A; Brockmeyer NH; German Competence Network HIV/AIDS. P16ink4a expression decreases during imiquimod treatment of anal intraepithelial neoplasia in HIV-infected men and correlates with the decline of lesional highrisk HPV-DNA load. British Journal of Dermatology 157; VOL: 523-30, 2007. [KompNet materialbank]

·         Mehandru S, Poles MA, Tenner-Racz K, Manuelli V, Jean-Pierre P, Lopez P, Shet A, Low A, Mohri H, Boden D, Racz P, Markowitz M. Mechanisms of Gastrointestinal CD4+ T-Cell Depletion during Acute and Early Human Immunodeficiency Virus Type 1 Infection. Journal of Neurology; VOL.: 81: 599–612, 2007.(2.903) [KompNet materialbank]

·         Von Geldern G; Cepok S; Nolting T; Du Y; Grummel V; Adams O; Hartung HP; Arendt G; Hemmer B. CD8 T-cell subsets and viral load in the cerebrospinal fluid of therapy-naive HIV-infected individuals. AIDS; VOL: 21(2):250-3, 2007. (IF 5.500) [KompNet materialbank]

 

2006

·         Epple HJ, Loddenkemper C, Kunkel D, Troeger H, Maul J, Moos V, Berg E, Ullrich R, Schulzke JD, Stein H, Duchmann R, Zeitz M, Schneider T. Mucosal but not peripheral FOXP3+ regulatory T cells are highly increased in untreated HIV infection and normalize after suppressive HAART. Blood May 25; 2006. (IF 10.131) [KompNet materialbank]

·         Kreuter A, U. Wieland, N.H. Brockmeyer. Genital human papillomavirus associated (pre-) malignant skin diseases drastically increase in the era of highly active antiretroviral therapy for HIV-infection. Journal of the American Academy of Dermatology 5ü/, 2006. (IF 2.402) [KompNet materialbank]

·         Kuate S, Stahl-Hennig C, Stoiber H, Nchinda G, Floto A, Franz M, Sauermann U, Bredl S, Deml L, Ignatius R, Norley S, Racz P, Tenner-Racz K, Steinman RM, Wagner R, Uberla K. Immunogenicity and efficacy of immunodeficiency virus-like particles pseudotyped with the G protein of vesicular stomatitis virus. Virology. 2006 Jul 20;351 (1):133-44. Epub 2006 Apr 17. (IF 3.042) [KompNet materialbank]

·         Mehandru S, Poles, MA, Tenner-Racz K, Jean-Pierre P, Manuelli V, Lopez P, Shet A, Low A, Mohri H, Boden D, Racz P, Markowitz M. Lack of mucosal immune reconstitution during prolonged treatment of acute and early HIV-1 infection P LoS Medicine 3(11): e484. doi:10.1371/journal.pmed.0040484, 2006. (IF 8.389) [KompNet materialbank]

 

2005

·         Kreuter A, N. Brockmeyer, B. Hochdorfer, S.J. Weissenborn, M. Stücker, J. Swoboda, P. Altmeyer, H. Pfister, U. Wieland: Clinical spectrum and virologic characteristics of anal intraepithelial neoplasia in HIV infection. Journal of the American Academy of Dermatology, 52, 603-608, 2005. (IF 2.402) [KompNet materialbank]

·         Kreuter A, N.H. Brockmeyer, H. Pfister, P. Altmeyer, U. Wieland. Human papillomavirus type 26 associated periungual squamous cell carcinoma in situ in a HIV-infected patient with concomitant penile and anal intraepithelial neoplasia. Journal of the American Academy of Dermatology 53, 737-739, 2005. (IF 2.402) [KompNet materialbank]

zurück zur Übersicht zurück zur Übersicht

Publikationen 2013

zurück zur Übersicht zurück zur Übersicht

Publikationen 2012

 

·        Etschel J.K., Hückelhoven A.G., Hofmann C., Zitzelsberger K., Maurer K., Bergmann S., Mueller-Schmucker S.M., Wittmann J., Spriewald B.M., Dörrie J., Schaft N. & Harrer T. HIV-1 mRNA electroporation of PBMC: A simple and efficient method to monitor T-cell responses against autologous HIV-1 in HIV-1-infected patients.  Journal of Immunological Methods 380 (2012) 40–55

·        Kasang C., Ulmer A., Donhauser N., Schmidt B., Stich A., Klinker H., Kalluvya S., Koutsilieri E., Rethwilm, A. & Scheller, C.HIV patients treated with low-dose prednisolone exhibit lower immune activation than untreated patients.  BMC Infectious Diseases 2012, 12:14

·        Pritschet K., Donhauser N. , Schuster P., Ries M., Haupt S., Kittan N.A., Korn K., Pöhlmann S., Holland G., Bannert N., Bogner E. & Schmidt B..CD4- and dynamin-dependent endocytosis of HIV-1 into plasmacytoid dendritic cells.  Virology 423 (2012) 152–164

·        Donhauser, N., Pritschet, K., Helm, M., Harrer, T., Schuster, P., Ries, M., Bischof, G., Vollmer, J., Smola, S. & Schmidt, B. Chronic Immune Activation in HIV-1 Infection Contributes to Reduced Interferon Alpha Production via Enhanced CD40:CD40 Ligand Interaction.  for the German Competence Network HIV/AIDS.. PLoS ONE (in press).

·        Liptrott N., Pushpakom S., Wyen C., Fätkenheuer G., Hoffmann C., Mauss S., Knechten H., Brockmeyer N.H., Hopper-Borge E., Back D., Khoo S., Pirmohamed M., Owen A.  Association of ABCC10 polymorphisms with nevirapine plasma concentrations in the German Competence Network for HIV/AIDS. on behalf of the German Competence Network for HIV/AIDS. Pharmacogenet Genomics. 2011 Nov 11. [Epub ahead of print]

·        Nolting T., Lindecke A., Hartung H.P., Koutsilieri E., Maschke M., Husstedt I.W., Sopper S., Stüve O., Arendt G. & the German Competence Network HIV/AIDS. Cytokine levels in CSF and neuropsychological performance in HIV patients.  J Neurovirol. 2012 Jun;18(3):157-61. Epub 2012 Apr 12.

·        Reinsch N., Neuhaus K., Esser S., Potthoff A., Hower M., Mostardt S., Neumann A., Brockmeyer N.H., Gelbrich G., Erbel R. & Neumann T. Are HIV patients undertreated? Cardiovascular risk factors in HIV: results of the HIV-HEART study. German Competence Network Heart Failure; German Competence Network for HIV/AIDS. . Eur J Prev Cardiol. 2012 Apr;19(2):267-74. Epub 2011 Feb 28.

zurück zur Übersicht zurück zur Übersicht

Publikationen 2011

·       Banasch M., Frank J., Serova K., Knyhala K., Kollar S., Potthoff A., Brockmeyer N.H., Goetze O. Impact of antiretroviral treatment on (13)C-methionine metabolism as a marker of hepatic mitochondrial function: a longitudinal study. HIV Med. 2011 Jan;12(1):40-5. (IF 2.878)

·       Deutsche AIDS-Gesellschaft (DAIG e.V.), Österreichische AIDS-Gesellschaft (ÖAG), KompNet HIV/AIDS et al. Leitlinie zur Diagnostik und Behandlung HIV-betroffener Paare mit Kinderwunsch. 2011.

·       Gelbrich B, Neumann T, Esser S, Potthoff A, Reinsch N, Hower M, Dannhauer KH, Loeffler M, Brockmeyer NH, Erbel R, Gelbrich G; HIV-HEARTStudy Investigative Group, Competence Networks HeartFailure and HIV/AIDS.Oral health and the heart – Does HIV infection open a pathophysiological gateway? Int J Cardiol. 2011;151(2):254-7. (Letter to the editor) Kohorte (Daten)

·       Judd et al. The Pursuing Later Treatment Options II (PLATO II) Project Team of COHERE. Risk of triple class virologic failure in HIVinfected children. Lancet. 2011, 7;377(9777):1580-7. Kohorte (Daten)

·       Kreuter A, Potthoff A, Brockmeyer N, Stücker M, Wieland U for the German Competence Network HIV/AIDS. HPV-73- and HPV-82 positive anal margin carcinoma with secondary ulcerating Herpes simplex-virus 2 infection. J Dtsch Dermatol Ges. 2011;9(8):628-30. (IF 1.403)

·       Liptrott NJ, Pushpakom S, Wyen C, Fätkenheuer G, Hoffmann C, Mauss S, Knechten H, Brockmeyer NH, Hopper-Borge E, Siccardi M, Back DJ, Khoo SH, Pirmohamed M, Owen A; on behalf of the German Competence Network for HIVAIDS. Association of ABCC10 polymorphisms with nevirapine plasma concentrations in the German Competence Network for HIV/AIDS. Pharmacogenet Genomics. 2011 Nov 11. [Epub ahead of print] Kohorte (Daten, Materialbank)

·       Mueller S.M., Spriewald B.M., Bergmann S., Eismann K., Leykauf M., Korn K., Walter H., Schmidt B, Arnold M.L., Harrer E.G., Kaiser R, Schweizer F, Braun P, Reuter S, Jaeger H, Wolf E, Brockmeyer N.H, Jansen K, Michalik C, Harrer T and the German Competence Network for HIV/AIDS. Influence of Major HIV-1 Protease Inhibitor Resistance Mutations on CTL Recognition. JAIDS, 2011;56(2):109-17. (IF 4.570) Kohorte (Daten, Materialbank)

·       Plettenberg A, Brockmeyer N H, Haastert B, Michalik C, Dupke S, Schewe K, Rausch M, Hower M, Ulmer A, Jäger H, Arendt G, Jansen K and the Competence Network for HIV/AIDS. Impact of earlier HAART initiation on immune status and clinical course of treated patients on basis of cohort data of the German Competence Network for HIV/AIDS, Infection, 2011;39(1):3-12. (IF 2.051) Kohorte (Daten)

·       Schipani A, Wyen C, Mahungu T, Hendra H, Egan D, Siccardi M, Davies G, Khoo S, Fätkenheuer G, Youle M, Rockstroh J, Brockmeyer NH, Johnson MA, Owen A, Back DJ; German Competence Network for HIV/AIDS. Integration of population pharmacokinetics and pharmacogenetics: an aid to optimal nevirapine dose selection in HIV-infected individuals. J Antimicrob Chemother. 2011;66(6):1332-9. Kohorte (Daten, Materialbank)

·       The Pursuing Later Treatment Option II (PLATO II) project team for the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) Group. Trendsin virological and clinical outcomes in individuals with HIV-1 infection and virological failure of drugs from three antiretroviral drug classes: a cohort study. Lancet Infect Dis. 2011 Oct 7. [Epub ahead of print].

·       Wyen C et al. on behalf of the German Competence Network for HIV/AIDS. Cytochrome P450 2B6 (CYP2B6) and constitutive androstane receptor (CAR) polymorphisms are associated with early discontinuation of efavirenz-containing regimens. J Antimicrob Chemother. 2011;66(9):2092-8. Kohorte (Daten, Materialbank)

zurück zur Übersicht zurück zur Übersicht

Publikationen 2010

·       Bohlius J. for the COHERE Study Group. HIV-1-related Hodgkin lymphoma in the era of combination antiretroviral therapy: incidence, outcome and evolution of CD4+ T cell lymphocytes. 2010, submitted. Kohorte (Daten)

·       Brockmeyer NH, Okamoto T. Abstracts of the 5th German-Japanese HIV-Symposium, Eur J Med Res 2010, 15(8): 323-37. (IF 1.130) u.a. Kohorte (Daten)

·       Brunne V. The Competence Network for HIV/AIDS from a health systems perspective: towards an impact assessment. 2010, in preparation.^

·       Bansi L, Sabin C, Delpech V, Hill T, Fisher M, Walsh J, Chadborn T, Easterbrook P, Gilson R, Johnson M, Porter K, Anderson J, Gompels M, Leen C, Ainsworth J, Orkin C, Nelson M, Rice B, Phillips A; UK Collaborative HIV Cohort (CHIC) Study and the Health Protection Agency. Trends over calendar time in antiretroviral treatment success and failure in HIV clinic populations. HIV Med. 2010;11(7):432-8.

·       Cohere Mortality project team for the Collaboration of Observational HIV Epidemiological Research Europe (COHERE). All-cause mortality in treated HIV-infected adults compared to the general population, a European cohort collaboration. 2010, submitted, Kohorte (Daten)

·       Donhauser, N., Helm, M., Pritschet, K., Schuster, P., Ries, M., Korn, K., Vollmer, J., & Schmidt, B. for the German Competence Network HIV/AIDS. Differential effects of P-class versus other CpG oligodeoxynucleotide classes on the impaired innate immunity of plasmacytoid dendritic cells in HIV-1 infection. AIDS Res Hum Retroviruses. 2010 Feb;26(2):161-71. (IF 2.178)

·       Khani S, Stankov M, Michalik C, Behrens G and the German Competence Network HIV/AIDS Cohort. Chronic systemic inflammation and immune reconstitution in HIVinfected patients. 2010, in preparation. Kohorte (Daten)

·       Klinische Arbeitsgemeinschaft AIDS Deutschland (KAAD), Österreichische AIDS-Gesellschaft (ÖAG). Leitlinie zur Therapie und Prophylaxe opportunistischer Infektionen bei HIV-infizierten Patienten - eine Leitlinie der KAAD unter Mitarbeit der ÖAG. 2010, in preparation.

·       Kreuter A, Potthoff A, Brockmeyer NH, Gambichler T, Swoboda J, Stücker M, Schmitt M, Pfister H, Wieland U. German Competence Network HIV/AIDS. Anal carcinoma in HIV-positive men: results of a prospective study from Germany. Br J Dermatol. 2010;162(6):1269-70. (IF 4.260) [Epub ahead of print] Kohorte (Daten, Materialbank)

·       Kreuter A, Jesse M, Potthoff A, Brockmeyer NH, Gambichler T, Stücker M, Bechara FG, Pfister H, Wieland U. Expression of proliferative biomarkers in anal intraepithelial neoplasia of HIV-positive men. J Am Acad Dermatol. 2010 Sep;63(3):490-8. (IF 4.105)

·       Kreuter A, Brockmeyer NH, Wieland U, für das deutsche Kompetenznetz HIV/AIDS. Anale intraepithelialer Neoplasie. Fortschritte der praktischen Dermatologie und Venerologie 2010, Springer.

·       PLATO II Project Team* for the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) Group*. Drug resistance associated mutations in patients who during the course of treatment develop virological failure to the three original classes of antiretroviral drugs. 2010, submitted, Kohorte (Daten)

·       Potthoff A, Brockmeyer NH. Current therapy of HIV. J Dtsch Dermatol Ges. 2010 Jan;8(1):45-56. (IF 1.403)

·       Potthoff A, Brockmeyer NH, Gelbrich G, Neuhaus K, Esser S, Reinsch N, Hower M, Mostardt S, Neumann A, Neumann T; Competence Center Cardiac Insufficiency and the Competence Network HIV/AIDS. Lipodystrophy – a sign for metabolic syndrome in patients of the HIV-HEART Study. J Dtsch Dermatol Ges. 2010 Feb;8(2):92-8. (IF 1.403) Kohorte (Daten)

·       Potthoff A, Brockmeyer NH, Stücker M, Wieland U, Kreuter A, Competence Network HIV AIDS. Kaposi sarcoma in a HIV uninfected man who has sex with men. Eur J Med Res. 2010 Feb 26;15(2):79-80. (IF 1.130)

·       Potthoff A. Impfungen bei Immunsupprimierten. Hautarzt 2010 2; 61:171. (IF 0.434)

·       Reinsch N, Neuhaus K, Esser S, Potthoff A, Hower M, Brockmeyer NH, Erbel R, Neumann T; German Competence Network for Heart Failure; German Competence Network for HIV AIDS. Prevalence of cardiac diastolic dysfunction in HIV-infected patients: results of the HIV-HEART study. HIV Clin Trials. 2010 ;11(3):156-62. (IF 1.626) Kohorte (Daten)

·       Reinsch N, Esser S, Sundermeyer  A, Neuhaus K, Brockmeyer  N, Potthoff A, Erbel R, Buck T, Neumann T for the HIV-HEART Study Investigative Group supported by the German Heart Failure Network and the Competence Network for HIV/AIDS. Echocardiographic findings in HIV-infected patients: Results from a large, prospective, multicenter HIV-Heart Study. HIV med 2010. In press. (IF 2.878) Kohorte (Daten)

·       Richel O, Wieland U, de Vries H, Brockmeyer N.H., van Noesel C, Potthoff A, Prins J.N., Kreuter A. Topical 5-fluorouracil treatment of anal intraepithelial neoplasia in HIV-positive men. Br J Dermatol. 2010 Aug 12. [Epub ahead of print] (IF 4.260)

·       Schipani A, Wyen C, Mahungu T.W, Hendra H, Egan D, Siccardi M, Davies G, Khoo S.H, Fätkenheuer G, Youle M, Brockmeyer N. H, Johnson M. A, Owen A, Back D.J. Integration of population pharmacokinetics and pharmacogenetics: an aid to optimal nevirapine dose selection in HIV-infected individuals. CPT, 2010, submitted, Kohorte (Daten, Materialbank)

·       Study Group on Death Rates at High CD4 Count in Antiretroviral Naive Patients, Lodwick RK, Sabin CA, Porter K, Ledergerber B, van Sighem A, Cozzi-Lepri A, Khaykin P, Mocroft A, Jacobson L, De Wit S, Obel N, Castagna A, Wasmuth JC, Gill J, Klein MB, Gange S, Riera M, Mussini C, Gutiérrez F, Touloumi G, Carrieri P, Guest JL, Brockmeyer NH, Phillips AN. Death rates in HIV-positive antiretroviral-naive patients with CD4 count greater than 350 cells per µL in Europe and North America: a pooled cohort observational study. Lancet. 2010 Jul 31;376(9738):340-5. (IF 30.758) Kohorte (Daten)

·       Verheyen, J., Schweitzer, F., Harrer, E.G., Knops, E., Mueller,S.M., Däumer, M., Eismann, K., Bergmann, S., Spriewald, B., Kaiser, R., Harrer,T. Analysis of immune selection as a potential cause for the presence of CS mutation 431V in treatment-naïve HIV-1 isolates. Antivir Ther. 2010;15(6):907-12. (IF 4.322)

·       Wyen C, Hendra H, Siccardi M, Platten M, Jaeger H, Harrer T, Esser S, Bogner J.R, Brockmeyer N.H, Bieniek B, Rockstroh J, Hoffmann C, Stoehr A, Michalik C, Dlugay V, Jetter A, Knechten H, Klinker H, Skaletz-Rorowski A, Faetkenheuer G, Egan D, Back D.J, Owen A and the German Competence Network for HIV/AIDS. Cytochrome P450 2B6 (CYP2B6) and Constitutive androstane receptor (CAR) polymorphisms are associated with early discontinuation of efavirenz - containing regimens. 2010, submitted, Kohorte (Daten, Materialbank)

·       Deutsche AIDS-Gesellschaft (DAIG e.V.), Österreichische AIDSGesellschaft (ÖAG), Deutsche AIDSHilfe e.V., Deutsche Arbeitsgemeinschaft niedergelassener Ärzte in der Versorgung von HIV- und AIDSPatienten (DAGNÄ e.V.), Deutsche Gesellschaft für Gynäkologie und Geburtshilfe (DGGG), Deutsche Vereinigung zur Bekämpfung der Viruskrankheiten (DVV), Kommission für Antivirale Chemotherapie der Gesellschaft für Virologie (GfV), Bundesverband reproduktionsmedizinischer Zentren Deutschlands e.V. (BRZ), Deutsche Gesellschaft für gynäkologische Endokrinologie und Fortpflanzungsmedizin (DGGEF), Robert-Koch-Institute (RKI) und das Kompetenznetz HIV/AIDS. Leitlinie zur Diagnostik und Behandlung HIV-Betroffener Paare mit Kinderwunsch. 2010 in preparation.

zurück zur Übersicht zurück zur Übersicht

Publikationen 2009

Kompetenznetz Publikationen 2009

Arendt, G. HIV und Alter. Medizinische Welt, 9/ 2009.

Brockmeyer NH, Okamoto T. 4th German-Japanese HIV-Symposium, 23rd-24th March 2009, Eur J Med Res 2009, 14(8): 332-44. (IF 1.130) (PDF, 10KB)

Brockmeyer N. H. Die nationale HIV-Kohorte – ein umfassendes Forschungsinstrument. Jahrbuch 2008/2009 der Deutschen AIDS-Hilfe e. V. S. 23-4.

Brockmeyer NH, Potthoff A. Mit der Lebenserwartung steigt das Tumorrisiko. Ärztliches Journal Onkologie; VOL: 3: 34-35, 2009.

Buchholz B, Beichert M, Marcus U, Grubert T, Gingelmaier A, Haberl A, Schmied B; German AIDS Society; Austrian AIDS Society; HIV-AIDS Competence Network; Robert-Koch Institute Berlin; German Association of Physicians Specialized in HIV Care; German Society of Pediatric and Youth Medicine; German AIDS Pediatric Association; German Society of Obstetrics and Gynecology; National Reference Center for Retroviruses; German AIDS Assistance. German-Austrian recommendations for HIV1-therapy in pregnancy and in HIV1-exposed newborn, update 2008. Eur J Med Res. 2009 Nov 3;14(11):461-79. (IF 1.130)

Burruano L, Skaletz-Rorowski A, Jansen K: Deutsch-ukrainische Zusammenarbeit im Bereich HIV/AIDS: Ukrainisches Zentrum für AIDS Prävention und Kompetenznetz HIV/AIDS schaffen epidemiologische Plattform und Zusammenarbeit zur Etablierung einer ukrainischen HIV-Kohorte, in: HIV&More 4/2009.

Brückner UW, Brockmeyer NH, Gödicke P, Kratz EJ, Scholz K, Taupitz J, Weber. Einbeziehung von volljährigen einwilligungsunfähigen Notfallpatienten in Arzneimittelstudien – Eine Handreichung für die Praxis. Deutsches Ärzteblatt, VOL.: 106(20), 2009.

Gemeinsame Empfehlung der DAIG und der ÖAG sowie der DAGNÄ, der DDG, der DGI, DGIM, der DGKH, der DGP, der DSTDG, der DGTI, der DTG, der Kommission für Antivirale Chemotherapie der GfV, der PEG, der DAH, der BZgA, des NRC, des RKI und des KompNet. Antiretrovirale Therapie der HIV-Infektion [Antiretroviral therapy of HIV infection]. Deutsche Medizinische Wochenschrift; VOL.: 134: S4, 2009. (IF 0.625)

Gemeinsame Empfehlung der DAIG und der ÖAG sowie der DAGNÄ, der DDG, der DGI, DGIM, der DGKH, der DGP, der DSTDG, der DGTI, der DTG, der Kommission für Antivirale Chemotherapie der GfV, der PEG, der DAH, der BZgA, des NRC, des RKI und des KompNet. Postexpositionelle Prophylaxe der HIV-Infektion. Deutsche Medizinische Wochenschrift; VOL.: 134: S16-S33, 2009. (IF 0.625)

Gemeinsame Erklärung der DAIG und der ÖAG; des KompNet sowie des RKI, der DAGNÄ, der DGKJ, der PAAD, derDGGG, des NRC, der DAH. German-Austrian recommendations for HIV treatment during pregnancy and for newborns exposed to HIV – Update 2008. Deutsche Medizinische Wochenschrift; VOL.: 134: S40, 2009. (IF 0.625)

Gröne M. Prepare for the long run – SÖDAK 2009. Retrovirus Bulletin 2009; 2:5-6.

Jansen K., N. H. Brockmeyer, M. Hahn, I. Kaul, S. Fenske, M. Rausch, B. Kuhlmann, A. Ulmer, E. Lauenroth-Mai, T. Harrer, M. Hower, A. Skaletz-Rorowski, C. Michalik, and the Competence Network for HIV/AIDS. Epidemiological composition, clinical and Treatment Characteristics fo the patient cohort of the German Competence Network for HIV/AIDS. Eur J Med Res 2009; 14: 415-25 (PDF, 1,5MB)

Jansen K. Aktuelle Ergebnisse der nationalen Patientenkohorte. HIV and More, 2009; 3: 39-40.

Jansen K. Die nationale HIV-Patientenkohorte – Ergebnisse aus einem umfassenden Forschungsinstrument. Medizinische Welt, 9/ 2009.

Jansen K, Michalik C. Nationale Patientenkohorte HIV/AIDS: Der Netzwerkgedanke funktioniert. Deutsche Zeitschrift für Klinische Forschung VOL.: 1/2, 2009.

Jansen K, Michalik C, Hahn M, Dupke S, Esser S, Jaeger H, Köppe S, Moll A, Plettenberg A, Schmidt RE, Skaletz-Rorowski A, Brockmeyer NH, and the Competence Network for HIV/AIDS. The Patient Cohort of the German Competence Network for HIV/AIDS (KompNet): a Profile. European Journal of Medical Research (2009) 14: 323-331. (IF 1.130) (PDF, 325KB)

Jansen K. Einkommen und gesundheitliche Lage von HIV-positiven Patienten. MedReport (2009) 24: 4.

Kremer H, Sonnenberg-Schwan U, Arendt G, Brockmeyer NH, Potthoff A, Ulmer A, Graefe K, Lorenzen T, Starke W, Walker UA; German Competence Network HIV/AIDS. HIV or HIV-therapy? Causal attributions of symptoms and their impact on treatment decisions among women and men with HIV. All Around Women Special, German AIDS Society, Eur J Med Res. 2009 Apr 16;14(4):139-46. (IF 1.040)

Kreuter A, Brockmeyer N.H., Wieland U, for the Competence Network for HIV/AIDS. Anale intraepithelial Neoplasie und Analkarzinom. Hautarzt, 2009. (IF: 0362)

Langer P, Drewes J, und das Kompetenznetz HIV/AIDS. Zur Bedeutung der Postexpositionsprophylaxe (PEP) in der HIV-Prävention – Ergebnisse einer Befragung von Schwerpunktzentren. Schriftenreihe des Arbeitsbereichs Prävention und psychosoziale Gesundheitsforschung; Nr. 01/P09, Berlin, 2009.

Lankisch TO, Behrens G, Ehmer U, Möbius U, Rockstroh J, Wehmeier M, Kalthoff S, Freiberg N, Manns MP, Schmidt RE, Strassburg CP. Gilbert's syndrome and hyperbilirubinemia in protease inhibitor therapy--an extended haplotype of genetic variants increases risk in indinavir treatment. J Hepatol. 2009;50:1010-8. (IF 7.818)

Neumann T, Reinsch N, Neuhaus K, Brockmeyer N. H., Potthoff A, Esser S, Hower M, Neumann A, Mostardt S, Gelbrich G, Erbel R.  für die HIV-HEART Studie on behalf of the German Competence Network of Heart Failure and the German Competence Network for HIV/AIDS. Wertigkeit des Biomarkers BNP bei HIV-infizierten Patienten BNP in HIV-infected Patients. Herz Vol. 34, No. 8., 1.12.2009, pp. 634-640.

Nolting T, Lindecke A, Koutsilieri E, Maschke M, Husstedt IW, Sopper S, Stüve O, Hartung HP, Arendt G., Competence Network HIV/AIDS. Measurement of soluble inflammatory mediators in cerebrospinal fluid of human immunodeficiency virus-positive patients at distinct stages of infection by solid-phase protein array. J Neurovirol. 2009 Dec;15(5-6):390-400. (IF 2.336)

Obermann M, Küper M, Kastrup O, Yaldizli O, Esser S, Thiermann J, Koutsilieri E, Arendt G, Diener HC, Maschke M; for the German Competence Network HIV/AIDS. Substantia nigra hyperechogenicity and CSF dopamine depletion in HIV. Journal of Neurology; 2009;256(6):948-53. (IF 2.536)

PENTA Steering Committee, Welch S, Sharland M, Lyall EG, Tudor-Williams G, Niehues T, Wintergerst U, Bunupuradah T, Hainaut M, Della Negra M, Pena MJ, Amador JT, Gattinara GC, Compagnucci A, Faye A, Giaquinto C, Gibb DM, Gandhi K, Forcat S, Buckberry K, Harper L, Königs C, Patel D, Bastiaans D. PENTA 2009 guidelines for the use of antiretroviral therapy in paediatric HIV-1 infection. HIV Med. 2009 Nov;10(10):591-613. (IF 2.878)

Potthoff A, Brockmeyer N, Götz Gelbrich, Neuhaus K, Esser S, Reinsch N, Hower M, Mostardt S, Neumann A, Neumann T, für das Kompetenznetz Herzinsuffizienz und das Kompetenznetz HIV/AIDS. Lipodystrophy – a sign for metabolic syndrome in patients of the HIV-HEART Study. J Dtsch Dermatol Ges. 2010 Feb;8(2):92-8.

Reinsch N., Neuhaus K., Krings P., Hower M., Becker-Boost I., Esser S., Potthoff A., Brockmeyer N.H., Erbel R, Neumann T, 1 on behalf of the German Heart failure Network and the German HIV/ AIDS Network. Prevalence and risc factors of prolonged QTc interval in HIV-infected patients: Results of the HIV-HEART-Study. HIV Clin Trials. 2009 Jul-Aug;10(4):261-8. (IF 1.626)

Stankov MV, Schmidt RE, Behrens GMN. Impact of stimulatory pathways on adipogenesis and HIV-therapy associated lipoatrophy. Exp Biol Med (Maywood). 2009 Dec;234(12):1484-92. (IF 2.635)

The Collaboration of Observational Epidemiologic Research Europe (COHERE) Study Group and members of the Cohere Study Group. Incidence and risk factors of HIV-related non-Hodkin’s lymphoma in the era of combination antiretroviral therapy: a European multicohort study. Antiviral Therapy 14:1056-1074, 2009. (IF: 4.332)

Common declaration of The German AIDS-socienty (DAIG), The Austrian AIDS-socienty (OEAG) of the HIV/AIDS Competence Network, et al. German-Austrian Recommendations for HIV1-Therapy in Pregnancy and in HIV1-exposed Newborn - Update 2008. Eur J Med Res. 14(11):461-79* (PDF, 333KB)

Langer, Phil. „EKAF“ AVANT LA LETTRE ? ART-bezogene Risikomanagement -strategien bei MSM in Deutschland. MedReview 2009; 10:19-20 (PDF, 80KB)

Publikationen von Wissenschaftlern aus dem Kompetenznetz HIV/AIDS 2009

COHERE Group. Prognosis of HIV-associated non-Hodgkin lymphoma in patients starting combination antiretroviral therapy: European multi-cohort study Article type: Original paper, AIDS 2009, accepted*

COHERE Group. Incidence and risk factors of HIV-related non-Hodgkin lymphoma in the era of combination antiretroviral therapy: European multi-cohort study. Antiviral Therapy 2009, accepted*

 

zurück zur Übersicht zurück zur Übersicht

Publikationen 2008

Kompetenznetz Publikationen 2008

Cagigi A, Mowafi F, Phuong Dang L, Tenner-Racz K, Atlas A, Grutzmeier S, Racz P, Chiodi F, Nilsson A. Altered expression of the receptor-ligand pair CXCR5/CXCL13 in B cells during chronic HIV-1 infection. Blood, VOL.: 112: 4401-4410, 2008*

**Frey UH, Lieb W, Erdmann J, Savidou D, Heusch G, Leinewebers K, Jakob H, Hense HW, Loewel H, Brockmeyer NH, Schundert H, Siffert W. Characterization of the GNAQ promoter and association of increased Gq expression with cardiac hypertrophy in humans. European Heart Journal; VOL.: 29: 888-897, 2008*

Bechara F.G., Sand M., Potthoff A., Altmeyer P., Brockmeyer N.H.; German Competence Network for HIV/AIDS. (2008). HIV-associated facial lipoatrophy-review of current therapy options. Eur J Med Res. 2008 Mar 31;13(3):93-9. Review.*

Behrens G. Therapeutic options for HIVassociated lipodystrophy. Expert Opinion on Pharmacotherapy; VOL: 9:39-52, 2008*

Brockmeyer N.H.: Gelungene Umstrukturierung – die Verkleinerung der Patientenkohorte führt zu einer Steigerung der Datenqualität. Med Welt 2008, 59: 60

Deutsche AIDS-Gesellschaft (DAIG), Österreichische AIDS-Gesellschaft (ÖAG), Deutsche Arbeitsgemeinschaft niedergelassener Ärzte in der Versorgung von HIV- und AIDS-Patienten (DAGNÄ), Deutsche AIDS-Hilfe (DAH), Bundeszentrale für gesundheitliche Aufklärung (BZgA), Nationales Referenzzentrum für Retroviren, Universität Erlangen/Nürnberg, Robert Koch-Institut (RKI), Kompetenznetz HIV/AIDS and Deutsche Gesetzliche Unfallversicherung (DGUV). German-Austrian recommendations for HIV Postexposure Prophylaxis. Eur J Med Res (2008) 13: 539-545*

Frey UH, Hauner H, Jöckel KH, Manthey I, Brockmeyer N. Siffert W. A novel promoter polymorphism in the human gene GNAS affects binding of transcription factor upstream stimulatory factor 1, Galphas protein expression and body weight regulation. Pharmacogenet Genomics. 2008 Feb;18(2):141-51*

Harrer T, Müller S, Harrer E. Interaktionen zwischen der HIV-1-spezifischen T-Zellantwort und der Entwicklung von Arzneimittelresistenzen bei HIV-1-infizierten Patienten. Med Welt 2008; 59: 66-69

Haupt S, Donhauser N, Chaipan C, Schuster P, Puffer B, Daniels RS, Grennoufh TC, Kirchhoff F, Schmidt B. CD4 Binding Affinity Determines Human Immunodeficiency Virus Type 1-Induced Alpha Interferon Production in Plasmacytoid Dendritic Cells. J Virol 2008; 82:8900-5*

Jansen K, Michalik C, Skaletz-Rorowski A, Esser S. Kompetenznetz HIV/AIDS: Weitere Förderung nach Umstrukturierung. HIV&more 2008; 3:44-47

Kreuter A., Brockmeyer N. H. Wieland U. (2008). Steigende Inzidenzen HPV-assoziierter analer Dysplasien und Analkarzinome bei HIV-infizierten Männern. HIV&More. Ausgabe 2

Kreuter A. Brockmeyer N.H., Altmeyer P., Wieland U., für das Deutsche Kompetenznetz HIV/AIDS (2008). Anale intraepitheliale Neoplasie bei HIV-Infektion [Anal intraepithelial neoplasia in HIV infection]. JDDG; 6: 925-934*

Kreuter A., Hochdorfer B., Brockmeyer N.H., Altmeyer P., Pfister H., Wieland U., Competence Network HIV/AIDS (2008). A human papillomavirus-associated disease with disseminated warts, depressed cell-mediated immunity, primary lymphedema, and anogenital dysplasia: WILD syndrome. Arch Dermatol; 144(3):366-72*

Kreuter A., Brockmeyer N.H., Weissenborn S.J., Gambichler T., Stuecker M., Altmeyer P., Pfister H., Wieland U., for the German Competence Network HIV/AIDS
Penile Intraepithelial Neoplasia Is Frequent in HIV-Positive Men with Anal Dysplasia
J Invest Dermatol. 2008 Sep;128(9):2316-24*

Kreuter A; Potthoff A; Brockmeyer NH; Gambichler T; Stücker M; Altmeyer P; Swoboda J; Pfister H; Wieland U. Imiquimod leads to a decrease of human papillomavirus DNA and to a sustained clearance of anal intraepithelial neoplasia in HIVinfected men. Journal of Investigative Dermatology; 128(8):2078-83; 2008*

Maurer K, Harrer E, Goldwich A., Eismann K, Bergmann S., Schmitt-Haendle M, Spriewald B, Mueller S, Harrer T., for the German Competence Network for HIV/AIDS. Role of Cytotoxic T-Lymphocyte-Mediated Immune Selection in a Dominant Human Leukocte Antigen-B8-Restricted Cytotoxic T-Lymphocyte Epitope in Nef. J Aqcuir Immune Defic Syndr 2008; 48(2):133-41*

Meisner F, Scheller C, Kneitz S, Sopper S, Neuen-Jacob E, Riederer P, ter Meulen V, Koutsilieri E; German Competence Network HIV/AIDS. Memantine upregulates BDNF and prevents dopamine deficits in SIV-infected macaques: a novel pharmacological action of memantine. Neuropsychopharmacology. 2008 Aug;33(9):2228-36*

Meissner F; Scheller C; Kneitz S; Sopper S; Neuen-Jacob E; Riederer P; ter Meulen V; Koutsilieri E. Memantine up-regulates BDNF and prevents brain dysfunction in HIV-infected macaques: a novel pharmacological action of memantine. Journal of Neurochem; VOL: 104(1):202-9.; 2008*

Meldung: Kohortenmanager des Kompetenznetz HIV/AIDS. HIV&more 2008; 3:66

Nattermann J, Vogel M, Nischalke HD, Danta M, Ahlenstiel G, Michalk M, Sauerbruch T, Rockstroh JK, Spengler U; Kompetenznetz HIV/AIDS. The transforming growth factor-beta high-producer genotype is associated with response to hepatitis C virus-specific therapy in HIV-positive patients with acute hepatitis C. AIDS. 2008 Jul 11;22(11):1287-92*

Potthoff A., Brockmeyer N.H., Skaletz-Rorowski A. For the German Competence Network HIV/AIDS (2008). Further developments in therapeutic strategies for HIV-infected adults. Eur Infect Dis. Vol. 2(1):31-4*

Potthoff A, Brockmeyer N.H. für das Kompetenznetzwerk HIV/AIDS. Manifestation und Management von Infektionen mit humanen Papillomviren bei HIV. Spektrum der Virologie 2008; 2:8-11

Schulbin H, Bode H, Stocker H, Schmidt W, Zippel T, Loddenkemper C, Engelmann E, Epple HJ, Arastéh K, Zeitz M, Ullrich R; Kompetenznetz HIV/AIDS Germany. Cytokine expression in the colonic mucosa of human immunodeficiency virus-infected individuals before and during 9 months of antiretroviral therapy. Antimicrob Agents Chemother. 2008 Sep;52(9):3377-84. Epub 2008 Jun 23*

Stankov MV, Schmidt RE, Behrens GM; German Competence Network HIV/AIDS. Zidovudine impairs adipogenic differentiation through inhibition of clonal expansion. Antimicrob Agents Chemother. 2008 Aug;52(8):2882-9. Epub 2008 May 12*

Tandler-Schneider A., U. Sonnenberg-Schwan, A. Gingelmaier, A. Meurer, H. Kremer, M. Weigel, P. Vernazza, B. Schmied, S. Klumb, A. Schafberger, M. Kupka, K. Friese, N. H. Brockmeyer. The following recommendations were adopted by the German AIDS Society(DAIG e.V.), the Austrian AIDS Society (OEAG), the German AIDS Help Organization (Deutsche AIDS Hilfe), the German Union of Registered Physicians in HIV and AIDS Patient Care (DAGNAE e.V.), the German Society for Obstetrics and Gynecology (DGGG) , the German Union for Combating Viral Diseases (DVV), the Commission for Antiviral Chemotherapy of the Virology Society (GfV), the German Federal Association of Reproductive Medical Centers e.V. (BRZ), the German Society for Gynecological Endocrinology and Reproductive Medicine (DGGEF), the Robert Koch Institute (RKI), and the Competence Network for HIV/AIDS. Diagnostics and treatment of HIV-affected couples who wish to have children. Eur J Med Res (2008) 13: 546-551*

Taubert S., Loss J.: Ärztliches Potenzial zur Prävention nutzen. Med. Welt 2008, Vol. 59: (S. 70-72)

Walter H. Pharmakogenetik und HIV-Therapie – Weshalb neue Arzneimittel eine spezifischere Diagnostik erfordern. [New drugs call for new diagnostic methods during antiretroviral therapy monitoring] Med. Welt 2008; 59: 61-64

Wyen C., Hendra H., Vogel M., Hoffmann C., Knechten H., Brockmeyer N.H., Bogner J.R., Rockstroh J., Esser S., Jaeger H., Harrer T., Mauss S., van Lunzen J., Skoetz N., Jetter A., Groneuer C., Fätkenheuer G., Khoo S. H., Egan D., Back D.J., Owern A., German Competence Network for HIV/AIDS (2008).Impact of CYP2B6 983T>C polymorphism on non-nucleoside reverse transcriptase inhibitor plasma concentrations in HIV-infected patient. J Antimicrob Chemother.2008; 61(4):914-8*

Zylka-Menhorn V, Siegmund-Schultze N, Bördlein I, Karolinska-Institut: Nobelpreis für den Virologen Harald zur Hausen. Deutsches Ärzteblatt; VOL.: 105(41): A-2133 / B-1831 / C-1787, 2008

Warpakowski A. HIV und Schwangerschaft: Zahl der Transmissionen zu hoch. Deutsches Ärzteblatt; VOL.: 105(20): A-1054 / B-914 / C-894, 2008

Zylka-Menhorn V. Sexuell übertragbare Erkrankungen (STD): „Safer-Sex“-Praktiken haben nach wie vor Priorität. Deutsches Ärzteblatt; VOL.: 105(12): A-619 / B-547 / C-535, 2008

Interview mit Prof Brockmeyer. 2007 war ein gutes Jahr für die HIV-Forschung. Deutsche Zeitschrift für Klinische Forschung; VOL.: 1-2: 69-71, 2008

Siegmund-Schultze. STD-Prävention ist auch HIV-Prävention. Forschung & Praxis; VOL.: 475: 18, 2008

Siegmund-Schultze. Für und Wider einer Therapie nach Gefühl. HIV & More; VOL.: 4: 54, 2008

Leiste A, Skaletz-Rorowski A, Venten I, Altmeyer P, Brockmeyer NH. Urticaria associated with Norovirus infection: Report of two cases. Journal der Deutschen Dermatologischen Gesellschaft; VOL.: 6: 1-10, 2008*


Publikationen von Wissenschaftlern aus dem Kompetenznetz HIV/AIDS2008 

Pathirana D, Hillemanns P, Petry K.U., Becker N., Brockmeyer N.H., Erdmann R., Gissmann L., Grundhewer H., Ikenberg H., Kaufmann A. M., Klußmann J. P., Kopp I., Pfister H., Rzany B., Schneede P., Schneider A., Smola S., Winter-Koch N., Wutzler P., Gross G. PEG-Empfehlungen: Impfprävention HPV-assoziierter Neoplasien. S3 Leitlinie der Arbeitsgruppe HPV-Management-Forum der Paul-Ehrlich-Gesellschaft für Chemothearpie e. V. Chemotherapie Journal 2008; 4:121-71

Tandler-Schneider A., Sonnenberg-Schwan U., Gingelmaier A., Meurer A., Kremer H., Weigel M., Vernazza P., Schmied B., Klumb S., Schafberger A., Kupka M., Friese K., Brockmeyer N.H. Diagnostik und Behandlung HIV-betroffener Paare mit Kinderwunsch. J Reproduktionsmed Endokrinol. 2008; 4:186-92

zurück zur Übersicht zurück zur Übersicht

Publikationen 2007

Kompetenznetz Publikationen 2007

Ahlenstiel G; Roomp K; Däumer M; Nattermann J; Vogel M; Rockstroh JK; Beerenwinkel N; Kaiser R; Nischalke HD; Sauerbruch T; Lengauer T; Spengler U; Kompetenznetz HIV/AIDS. Selective pressures of HLA genotypes and antiviral therapy on human immundeficiency virus type 1 sequence mutation at a population level. Clinical and vaccine immunology; VOL: 14 (10): 1266-73; 2007.

Antinori A; Arendt G; Becker. JT; Brew BJ; Byrd DA; Cherner M; Clifford DB; Cinque P; Epstein LG; Goodkin K; Gisslen M; Grant I; Heaton RK; Joseph J; Marder K; Marra CM; McArthur JC; Nunn M; Price RW; Pulliam L; Robertson KR; Sacktor N; Valcour V; Wojna VE. Updated research nosology for HIV-associated neurocognitive disorders. Neurology; VOL: 69(18): 1789-99, 2007.

Arendt G; Nolting T; Frisch C; Husstedt IW; Gregor N; Koutsilieri E; Maschke M; Angerer A; Obermann M; Neuen-Jacob E; Adams O; Loeffert, S; Riederer P; ter Arendt G; de Nocker D; von Giesen HJ; Nolting T. Neuropsychiatric side effects of efavirenz therapy. Expert opinion on drug safety; VOL: 6(2):147-54, 2007.

Baethge C. Global theme issue on poverty and human development: Poverty and Health. Deutsches Ärzteblatt 2007; 104(43): A-2905 / B-2561 / C-2485, 2007.

Breuckmann F; Nassenstein K; Kondratieva J; Esser S; Erbel R; Potthoff A; Brockmeyer NH; Neumann T; Barkhausen J; German Heart Failure Network; Competence Network HIV/AIDS. Characterization of cardiac abnormalities in HIV+ individuals with increased BNP levels. European journal of medical research; VOL: 12(5): 185-190,2007.

Brockmeyer N. Skaletz-Rorowski A. Kompetenznetz als kompetenter Partner für den internationalen Kampf gegen AIDS vorgestellt. Fünf Jahre Kompetenznetz HIV/AIDS: Feuertaufe bestanden und eingebunden in Europa. Medizinische Welt 6; 58: 278-82, 2007.

Brockmeyer NH, Potthoff A. Perspektiven der HIV-Forschung MedReview, 9:6-7, 2007.

Brunne V. Cepok S; von Geldern G; Nolting T; Grummel V; Srivastava R; Zhou D; Hartung HP; Adams O; Arendt G; Hemmer B. HIV/Aids: Wie Aids die Weltwirtschaft schwächt. Deutsches Ärzteblatt 2007; 104(43): A-2932 / B-2582 / C-2505, 2007 Viral load determines the B-cell response in the cerebrospinal fluid during human immunodeficiency virus infection. Annals of neurology; VOL: 62(5): 458-67, 2007.

Emmelkamp JM; Rockstroh JK. CCR5 antagonists: comparson of efficacy; side effects; pharmacokinetics and interactions – review of the literature. European journal of medical research; VOL: 12(9): 409-17, 2007.

Gómez CE, Nájera JL, Jiménez EP, Jiménez V, Wagner R, Graf M, Frachette MJ, Liljeström P, Pantaleo G, Esteban M. Head-to-head comparision of the immunogenicity of two HIV/AIDS vaccine candidates based on the attenuated poxvirus strains MVA and NYVAC coexpressing in a single locus the HIV-1 BX08 gp120 and HIV-1 IIIB Gag-Pol-Nef proteins of clade B. Vaccine; VOL.: 25:2863-85, 2007.

Gómez CE, Nájera JL, Jiménez V, Bieler K, Wild J, Kostic L, Heidari S, Chen M, Frachette MJ, Pantaleo G, Wolf H, Liljeström P, Wagner R, Esteban M. Generation and immunogenicity of novel HIV/AIDS vaccine candidates targeting HIV-1 Env/Gag-Pol-Nef antigens of clade C. Vaccine; VOL.: 25:1969-92, 2007.

Harari A, Cellerai C, Enders FB, Köstler J, Codarri L, Tapia G, Boyman O, Castro E, Gaudieri S, James I, John M, Wagner R, Mallal S, Pantaleo G. Skewed association of polyfunctional antigen-specific CD8 T cell populations with HLA-B genotype. Proceedings of the National Academy of Sciences of the United States of America; VOL.: 104(41):16233-8, 2007.

Janowicz DM, Tenner-Racz K, Racz P, Humphreys TL, Schnizlein-Bick C, Fortney KR, Zwickl B, Katz BP, Campbell JJ, Ho DD, Spinola SM. Experimental infection with Haemophilus ducreyi in persons who are infected with HIV does not cause local or augment systemic viral replication. The Journal of infectious diseases; VOL.:195: 1443-51, 2007.

Kneitz S; Meisner F; Sopper; S; Kaiser F; Grünblatt E; Scheller C; Riederer P; ter Meulen V; Koutsilieri E. Biostatistical analysis of gene microarrays reveals diverse expression clustern between macaque subspecies in brain SIV infection. Journal of neural transmission Supplement; VOL: 72:317-22, 2007.

Kreuter A; Brockmeyer N; Pfister H; Altmeyer P; Wieland U; German Competence Network HIV/AIDS. Increased HPV31 DNA load in a verrucous high-grade intraepithelial neoplasia of a HIV-infected patient with extensive bowenoid papulosis. British Journal of Dermatology; VOL: 156; 596-8, 2007.

Kreuter A; Brockmeyer N; Wieland U; German Competence Network HIV/AIDS. Irregular shaped Leukoplakic Lesions of the Anus Clinical and Experimental. Dermatology; VOL: 32; 621-3; 2007.

Kreuter A; Brockmeyer NH; Altmeyer P; Pfister H; Wieland U; German Competence Network HIV/AIDS. Rapid onset of multifocal HPV72-associated oral intraepithelial neoplasia in a HIVinfected patient. British Journal of Dermatology; VOL: 157; 826-8, 2007.

Kreuter A; Wieland U; Gambichler T; Altmeyer P; Pfister H; Tenner-Racz K; Racz P; Potthoff A; Brockmeyer NH; German Competence Network HIV/AIDS. P16ink4a expression decreases during imiquimod treatment of anal intraepithelial neoplasia in HIV-infected men and correlates with the decline of lesional highrisk HPV-DNA load. British Journal of Dermatology 157; VOL: 523-30, 2007.

Larke N, Im EJ, Wagner R, Williamson C, Williamson AL, McMichael AJ, Hanke T. Combined single-clade candidate HIV-1 vaccines induce T cell responses limited by multiple forms of in vivo immune interference. European J Immunology; VOL.: 37(2):566-77, 2007.

Lebrecht D; Vargas-Infante YA; Setzer B; Kirschner J; Walker UA. Uridine supplementation antagonizes zalcitabine-induced microvesicular steatohepatitis in mice. Hepatology; VOL: 45(1):72-9, 2007.

Manns MP; Foster GR; Rockstroh JK; Zeuzem S; Zoulim F; Houghton M. The way forward in HCV treatment – finding the right path. Nature reviews. Drug discovery; VOL: (12): 991-1000, 2007.

Marcondes M; Burdo T; Sopper S; Huitron-Resendiz S; Lanigan C; Watry D; Flynn C; Zandonatti M;F Fox. Early enrichment and persistence of virus specific CTL in the brain of SIV-infected monkeys is associated with a unique cytokine environment. Journal of immunology; VOL: 178:5812-9, 2007.

Mehandru S, Poles MA, Tenner-Racz K, Manuelli V, Jean-Pierre P, Lopez P, Shet A, Low A, Mohri H, Boden D, Racz P, Markowitz M. Mechanisms of Gastrointestinal CD4+ T-Cell Depletion during Acute and Early Human Immunodeficiency Virus Type 1 Infection. Journal of Neurology; VOL.: 81: 599–612, 2007.

Meiselbach H; Horn AHC; Harrer T; Sticht H. Insights into Amprenavir resistance in E35D HIV-1 protease mutation from molecular dynamics and binding free energy calculations. Journal of molecular modeling; VOL: 13(2):297-304, 2007.

Meiser F; Scheller C; Neuen-Jacob E; Sopper S; Vosswinkel D; ter Meulen V; Koutsilieri E, for the German Competence Network HIV/AIDS. Neurodysfunction in immmunodefeiciency virus-infected subjects is due to disruption of the glutamatergic synapse. European journal of medical research; VOL: 12 (Suppl II) 56-7; 2007.

Merten M Das Porträt: Dr. med. Heiko Jessen, HIV-Spezialist – Freund. Vater. Arzt. Deutsches Ärzteblatt; 104(48): A-3309 / B-2909 / C-2809, 2007.

Metzner KJ; Allers K; Rauch P; Harrer T. Rapid selection of drug-resistant HIV-1 during the first months of suppressive ART in treatmentnaïve patients. AIDS; VOL: 21(6): 703-11, 2007.

Meulen V; Sopper S; German Competence Network HIV/AIDS. Intrathecal viral replication and cerebral deficits in different stages of human immunodeficiency virus disease. Journal of neurovirology; VOL: 13(3):225-32, 2007.

Morozov VA, Morozov AV, Schürmann D, Jessen H, Kücherer C. Transmembrane protein polymorphisms and resistance to T-20 (Enfuvirtide, Fuzeon) in HIV-1 infected therapy-naive seroconverters and AIDS patients under HAART-T-20 therapy. Virus Genes. VOL.:35(2):167-74, 2007.

Mueller SM; Schaetz B; Eismann K; Bergmann S; Baeuerle M; Schmitt-Haendle M; Walter H; Schmidt B; Korn K; Sticht H; Spriewald B; Harrer EG; Harrer T. Dual selection pressure by drugs and HLA class I-restricted immune responses on HIV-1 protease. Journal of virology; VOL: 81(6):2887-98, 2007.

Nattermann J; Vogel M; Berg T; Danta M; Axel B; Mayr C; Bruno R; Tural C; Klausen G; Glotet B; Lutz T; Grünhage F; Rausch M; Nischalke HD; Schewe K; Bienek B; Haerter G; Sauerbruch T; Rockstroh JK; Spengler U; Kompetenznetz HIV/AIDS. Effect of the interleukin-6 C174 gene polymorphism on treatment of acute and chronic hepatitis C in human immundeficiency virus co-infected patients. Hepatology; VOL: 46(4): 1016-25; 2007.

Poggensee G, Kücherer C, Werning J, Somogyi S, Bieniek B, Dupke S, Jessen H, Hamouda O; HIV-1 Seroconverter Study Group. Impact of transmission of drugresistant HIV on the course of infection and thetreatment success. Data from the German HIV-1 Seroconverter Study. HIV medicine; VOL.:8(8):511-9, 2007.

Potthoff A; Brockmeyer NH; Kompetenznetz HIV/AIDS. HIV-Infektion 2007 Medizinische Klinik; VOL: 102:531–9, 2007.

Riemann K; Adamzik M; Frauenrath S; Egensperger R; Schmid KW; Brockmeyer NH, Siffert W. Comparison of manual and automated nucleic acid extraction from whole-blood samples. Journal of clinical laboratory analysis; 21(4): 244-8, 2007.

Sonnenberg-Schwan U, Kremer H. HIV oder (HA)ART)? Wo sehen Männer und Frauen die Ursache ihrer Beschwerden? Projekt Information, Jahrgang 15, Nr. 6: 14-15, 2007.

Sonnenberg-Schwan U, Kremer H. HIV oder (HA)ART? DHIVA Zeitschrift für Frauen, Gesundheit und AIDS; 37: 9, 2007.

Stankov M; Behrens GMN HIV-therapy associated lipodystrophy: experimental and clinical evidence for the pathogenesis and treatment Current drug targets. Immune, endocrine and metabolic disorder; VOL.: 7: 237-49, 2007.

Stankov M; Lücke T; Das AM; Schmidt RE; Behrens GMN; German Competence Network HIV/AIDS. Relationship of mitochondrial DNA depletion and respiratory chain activity in preadipocytes treated with nucleoside-analogue reverse transcriptase inhibitors Antiviral therapy; VOL: 12: 205-16, 2007.

Taubert S. (Aids-Hilfe as a part of the Competence Network. Mediators between research and patient. Aids-Hilfe im Kompetenznetz HIV/AIDS. Mittler zwischen Forschung und Patient/in. HIVandMore 2/2007, June 2007.

Taubert S. Was einem offenen Gespräch im Weg steht. Ein Forschungsprojekt der Deutschen AIDS Hilfe (Barriers for a successful communication between physicians and patients. A Research project of the Deutsche AIDS Hilfe.) Deutsches Ärzteblatt. No. 48. November, 2007.

Vogel M, Rockstroh JK Chronic HIV-infection, current therapeutic aspects. Internist; 48: 2519-24, 2007.

Von Geldern G; Cepok S; Nolting T; Du Y; Grummel V; Adams O; Hartung HP; Arendt G; Hemmer B. CD8 T-cell subsets and viral load in the cerebrospinal fluid of therapy-naive HIV-infected individuals. AIDS; VOL: 21(2):250-3, 2007.

Warpakowski A 3. Deutsch-Oesterreichischer AIDS-Kongress: Aktuelle Daten zeigen gute Behandlungsqualität. Deutsches Ärzteblatt; 104(28-29): A-2034 / B-1793 / C-1729, 2007.

Wasmuth JC, Rockstroh JK. HIV-infection Deutsche Medizinische Wochenschrift; 132: 673-683, 2007.

Zylka-Menhorn V Wenn HIV das Herz erobert. Medizinische Welt 6; 58, 2007.

 

zurück zur Übersicht zurück zur Übersicht

Publikationen 2006

Arendt G, Nolting T. Apathie, Depression, Fatigue – Beeinträchtigungen HIV-positiver Menschen im Alltagsleben. German. MMW, 2006.

Arendt G, T. Nolting, C. Frisch, I.W. Husstedt., N. Gregor, E. Koutsilieri, M. Maschke, A. Angerer, M. Obermann, E. Neuen-Jacob, O. Adams, S. Loeffert, P. Riederer, V. ter Meulen, S. Sopper, for the Competence Network HIV/AIDS,Germany. Intrathecal viral replication and cerebral deficits in different stages of HIV disease. Journal of Neurovirology, Vol. 13, No. 3, Pages 225-232, 2007.

Arendt G. Affective disorders in patients with HIV infection: impact of antiretroviral therapy. CNS Drugs.;20(6):507-18. Review, 2006. (IF 3.671)

Bäuerle M., Schröppel K., Taylor B., Bergmann S., Schmitt-Haendle M., Harrer T. Analysis of the Candida albicans - specific T-cell response and oropharyngeal Candida albicans colonisation in a cohort of HIV-1-infected patients. The European Journal of Medical Research, 2006. (IF 0.944)

Behrens GMN, Moebius U, Gurjanov A, Mischak H, Schmidt RE, Wittke S. Urinary proteome analysis by capillary electrophroesis coupled mass spectrometry (CE-MS) for detection of tenofovir-associated kidney damage in HIV patients. Antivir Ther; 11:L14, 2006.

Berg T, von Wagner M, Nasser S, Sarrazin C, Heintges T, Gerlach T, Buggisch P, Goeser T, Rasenack J, Pape GR, Schmidt WE, Kallinowski B, Klinker H, Spengler U, Martus P, Alshuth U, Zeuzem S. Extended treatment duration for hepatitis C virus type 1: comparing 48 versus 72 weeks of peginterferon-alfa-2a plus ribavirin. Gastroenterology. Apr;130(4):1086-97, 2006. (IF 12.386)

Bredl S., Wiesel M., Deml L., Wild J. and Wagner R. Activation of Innate Immune Responses by Human Immunodeficiency Virus Type-1 (HIV-1) Pr55gag Virus-Like Particles (VLP). AIDS Vaccine Conference Amsterdam, 2006.

Brockmeyer N.H. et al. Kompetenznetz HIV/AIDS – Forschungsverbund mit stolzer Bilanz. Med Welt 57: 489-492, 2006.

Brockmeyer N.H. Kompetenznetz HIV/AIDS, Med Welt 57: 485, 2006.

Buchholz B, Beichert M, Marcus U, Grubert T, Gingelmaier A, Haberl A, Schmied B, Brockmeyer N. German-Austrian Recommendations for HIV-therapy in pregnancy and in HIV-exposed newborn - update 2005 Common declaration of the German AIDS-society (DAIG), the Austrian AIDS-society (OEAG) and of the HIV-AIDS competence network. Eur J Med Res 1: 359-376, 2006. (IF 0.994)

Epple HJ, Loddenkemper C, Kunkel D, Troeger H, Maul J, Moos V, Berg E, Ullrich R, Schulzke JD, Stein H, Duchmann R, Zeitz M, Schneider T. Mucosal but not peripheral FOXP3+ regulatory T cells are highly increased in untreated HIV infection and normalize after suppressive HAART. Blood May 25; 2006. (IF 10.131)

Feldmann G, Nischalke HD, Nattermann J, Banas B, Berg T, Teschendorf C, Schmiegel W, Duhrsen U, Halangk J, Iwan A, Sauerbruch T, Caselmann WH, Spengler U. Induction of interleukin-6 by hepatitis C virus core protein in hepatitis C-associated mixed cryoglobulinemia and B-cell non-Hodgkin's lymphoma. Clin Cancer Res. Aug 1;12(15):4491-8, 2006. (IF 5.715)
Gurjanov A, Gerschmann S, Lubach-Ruitmann M, Stoll M, Schmidt RE, Behrens GMN. Time until change of first-line antiretroviral therapy in patients receiving NNRTI and protease inhibitor (PI)-containing regimens. Antivir Ther, 2006. (IF  5.286)

Hentig N, Carlebach A, Gute P, et al. A comparison of the steady-state pharmacokinetics of nevirapine in men, nonpregnant women and women in late pregnancy. Br J Clin Pharmacol, 2006. (IF 2.777)

Hentrich M, Maretta L, Chow KU, Bogner JR, Schurmann D, Neuhoff P, Jager H, Reichelt D, Vogel M, Ruhnke M, Oette M, Weiss R, Rockstroh J, Arasteh K, Mitrou P. Highly active antiretroviral therapy (HAART) improves survival in HIV-associated Hodgkin's disease: results of a multicenter study. Ann Oncol. Jun;17(6):914-9, 2006. (IF 4.319)

Kellinghaus C, Wibbeke B, Evers S, Reichelt D, Pollmann H, Husstedt IW. Neurophysiological abnormalities in HIV-infected long term survivors. Eur J Med Res. Jun 30;11(6):245-9, 2006. (IF 0.944)

Kreuter A, Norbert H. Brockmeyer, Ulrike Wieland, MD; for the German Competence Network HIV/AIDS. Clinicopathological case Irregular Shaped Leucoplakic Lesion of the Anus. Clinical and Experimental Dermatology, 2006. (IF 1.426)

Kreuter A, U. Wieland, A. Potthoff, P. Altmeyer, N. Brockmeyer. HPV-assoziierte Tumoren bei HIV-Infektion. Med Welt 57, 2006.

Kreuter A, U. Wieland, N. Brockmeyer. Analkarzinom und anale intraepitheliale Neoplasie bei HIV-Infektion. JDDG 7 (Band 4), 2006.

Kreuter A, U. Wieland, N.H. Brockmeyer. Genital human papillomavirus associated (pre-) malignant skin diseases drastically increase in the era of highly active antiretroviral therapy for HIV-infection. Journal of the American Academy of Dermatology 5ü/, 2006. (IF 2.402)

Kreuter A., Wieland U., Potthoff A., Altmeyer P., Brockmeyer N. HPV-assoziierte Tumoren bei HIV-Infektion. Med. Welt 57 498-502, 2006.

Kreuter, N. Brockmeyer, H. Pfister, P. Altmeyer, U. Wieland. Increased HPV31 DNA load in a verrucous high-grade intraepithelial neoplasia of a HIV-infected patient with extensive bowenoid papulosis. British Journal of Dermatology, 2006. (IF 2.445)

Kreuter, N.H. Brockmeyer, S.J. Weissenborn, A. Wafaisade, H. Pfister, P. Altmeyer, U. Wieland. 5% Imiquimod suppositories decrease the DNA-load of intra-anal HPV types 6 and 11 in HIV-infected men after surgical ablation of condylomata acuminate. Archives of Dermatology 142, 243-244, 2006. (IF 0.740)

Kruse G. Therapeutisches Drug Monitoring von Nukleosidalen Reverse Transkriptase Inhibitoren. 1 ed. Köln: Kölner Wissenschaftsverlag, 2006.

Kuate S, Stahl-Hennig C, Stoiber H, Nchinda G, Floto A, Franz M, Sauermann U, Bredl S, Deml L, Ignatius R, Norley S, Racz P, Tenner-Racz K, Steinman RM, Wagner R, Uberla K. Immunogenicity and efficacy of immunodeficiency virus-like particles pseudotyped with the G protein of vesicular stomatitis virus. Virology. 2006 Jul 20;351 (1):133-44. Epub 2006 Apr 17.

Lankisch T, Moebius U, Wehmeier M, Behrens G, Manns MP, Schmidt RE, Strassburg CP. Gilbert’s disease and atazanavir: From phenotype to UDP-glucuronyltransferase haplotype. 57th Annual Meeting of the American Association for the Study of Liver Diseases, Hepatology; 44 (suppl 1): 210A, 2006. (IF 9.792)

Lebrecht D, YA. Vargas-Infante, B. Setzer, J. Kirschner and UA. Walker. Uridine supplementation antagonizes zalcitabine-induced microvesicular steatohepatitis in mice. Hepatology, 2006. (IF 9.792)

Mauss S, Behrens G, Walker U. Appendix to the German-Austrian HIV Therapeutic Guidelines: strategies for treating morphological and metabolic alterations under antiretroviral treatment. Eur J Med Res. Feb 21;11(2):47-57, 2006. (IF 0.994)

Mehandru S, Poles MA, Tenner-Racz K, Manuelli V, Jean-Pierre P, Lopez  P, Shet A, Low A, Mohri  H, Boden D, Racz  P,  Markowitz  M. Mechanisms of gastrointestinal CD4+ T cell depletion during acute and early HIV-1 infection. J Virol doi:10.1128/JVI.01739-06, 2006. (IF 5.178)

Mehandru S, Poles, MA, Tenner-Racz K, Jean-Pierre P, Manuelli V, Lopez P, Shet A, Low A, Mohri H, Boden D, Racz P, Markowitz M. Lack of mucosal immune reconstitution during prolonged treatment of acute and early HIV-1 infection P LoS Medicine 3(11): e484. doi:10.1371/journal.pmed.0040484, 2006. (IF 8.389)

Meiselbach, H., Horn, A.H.C., Harrer, T, Sticht, H. Insights into Amprenavir resistance in E35D HIV-1 protease mutation from molecular dynamics and binding free energy calculations. Journal of Molecular Modeling. 2006 Jun 23. (IF 1.670)

Metzner K.J., Allers K., Rauch P., Harrer T. Rapid selection of drug-resistant HIV-1 during the first months of suppressive ART in treatment-naïve patients, in AIDS, 2006. (IF 5.835)

Mueller, S.M., Schaetz, B., Eismann, K., Bergmann, S., Baeuerle, M., Schmitt-Haendle, M., Walter, H., Schmidt, B., Korn, K., Sticht, H., Spriewald, B., Harrer, E.G., Harrer, T. Dual selection pressure by drugs and HLA class I-restricted immune responses on HIV-1 protease. In Revision at the Journal of Virology, 2006. (IF 5.178)

Nattermann J, Ahlenstiel G, Berg T, Feldmann G, Nischalke HD, Muller T, Rockstroh J, Woitas R, Sauerbruch T, Spengler U. The tandem-repeat polymorphism of the DC-SIGNR gene in HCV infection. J Viral Hepatitis Jan;13(1):42-6, 2006. (IF 2.550)

Neifer S., Somogyi S., Schlote F., Berg T., Poggensee G., Kuecherer C. Persistence of a sexually transmitted highly resistant HIV-1: pol quasispecies evolution during 33 months in the absence of treatment. AIDS, 2006. (IF 5.835)

Oette M, Kaiser R, Daumer M, Petch R, Fatkenheuer G, Carls H, Rockstroh JK, Schmaloer D, Stechel J, Feldt T, Pfister H, Haussinger D. Primary HIV drug resistance and efficacy of first-line antiretroviral therapy guided by resistance testing. J Acquir Immune Defic Syndr Apr 15;41(5):573-81, 2006.(IF 4.100)

Pillay D, Bhaskaran K, Jurriaans S, Prins M, Masquelier B, Dabis F, GiffordR, Nielsen C, Pedersen C, Balotta C, Rezza G, Ortiz M, de Mendoza C, Kucherer C, Poggensee G, Gill J, Porter K; CASCADE Virology Collaboration. The impact of transmitted drug resistance on the natural history of HIV infection and response to first-line therapy. AIDS 20:21-8, 2006. (IF 5.835)

Potthoff A., Brockmeyer N.H. HIV-associated tumors. Hautarzt 57(11): 988-993, 2006. (IF 0.535)

Potthofff A., Brockmeyer N.H. Krankheiten durch das humane Immundefizienzvirus (HIV). Urologe, 2006. (IF 0.471)

Scheller C, J. Knöferle, A. Ullrich, J. Prottengeier, T. Racek, S. Sopper, C. Jassoy, A. Rethwilm and E. Koutsilieri. Caspase inhibition in apoptotic T cells triggers necrotic cell death depending on the cell type and the proapoptotic stimulus. J Cell Biochem, 2006. (IF 3.591)

Schmid,H, D Mühlbayer, J Rölling, T Sternfeld, B Jülg, U Schlattner, J R Bogner, T Wallimann, F-D Goebel. Macroenzyme Creatine Kinase Type 2 in sera of HIV Infected Patients is significantly associated with Tenofovir DF Treatment and consists of ubiquitous mitochondrial CK. Antiviral Therapy, 2006. (IF  6.036)

Schmidt B, Tschochner M, Walter H, Korn K. Managing antiretroviral resistance. In: Bogner E, Holzenburg A (eds.). New concepts of antiviral therapies. Springer, New York, Dodrecht, 2006.
Schofer H, Brockmeyer NH, Hagedorn HJ, Hamouda O, Handrick W, Krause W, Marcus U, Munstermann D, Petry KU, Prange H, Potthoff A, Gross G. Syphilis. Guideline of the German Sexually Transmitted Diseases Society fo diagnosis and therapy of syphilis. J Dtsch Dermatol Ges. Feb;4(2):160-77, 2006.

Schofer H., Brockmeyer N.H. Brief guidelines – Kaposi sarcoma. J Dtsch Dermatol Ges 4(7): 586-90, 2006.

Schulbin H. Effects of HAART on the gut mucosal immune system in HIV-infected patients. Berlin: Freie Universität Berlin, 2006.

Sing T, Tschochner M, Weisser H, Verheyen J, Daumer M, Kaiser R, Korn K, Walter H, Lengauer T. Predictive and interpretable models relating HIV-1 gag/pol genotype to replication capacity. 4th European HIV Drug Resistance Workshop, Monaco, Monte Carlo, March 29-31, 2006.

Skoetz N, Brockmeyer NH. Nationales Patientenregister KN HIV/AIDS. Kompetenznetze in der Medizin: von der Forschung in die Versorgung. Schriftenreihe des Bundesministeriums für Bildung und Forschung, 2006.

Skoetz N., Wiegelmann, Brockmeyer N. H. 2 Jahre Patientenregister des Kompetenznetzes HIV/AIDS – erste Ergebnisse. Med. Welt 57: 494-497, 2006.

Stankov M, Lücke T, Das A, Schmidt RE, Behrens GMN. Nucleoside reverse transcriptase inhibitors in murine and human adipocytes: impact on mitochondrial DNA depletion and respiratory chain acitivity. Antivir Ther, 2006.

Stankov M, Lücke T, Das AM, Schmidt RE, Behrens GMN; German Competence Network HIV/AIDS. Relationship of mitochondrial DNA depletion and respiratory chain activity in preadipocytes treated with nucleoside-analogue reverse transcriptase inhibitors. Antivir Ther, 2006. (IF 6.036)

Stellbrink H.-J. Warum wir die HIV-Infektion derzeit nicht heilen können. Med Welt 57: 503-508, 2006.

Sternfeld T, M Schmid, A Tischleder, S Mudra, A Schlamp, B P Kost, R Gruber, M Youle, J R Bogner, F D Goebel. Mitochondrial membrane potential of peripheral mononuclear cells as a marker for mitochondrial function during HIV infection. Antivir Ther. 2007;12 (5):769-78.

Stocker H, Kloft C, Plock N, et al. Pharmacokinetics of enfuvirtide in patients treated in typical routine clinical settings. Antimicrob Agents Chemother, 50:667-673, 2006. (IF 4.379)

Streeck H, Jessen H, Alter G, Teigen N, Waring MT, Jessen A, Stahmer I, Lunzen J, Lichterfeld M, Gao X, Allen TM, Carrington M, Walker BD, Rockstroh JK, Altfeld M. Immunological and Virological Impact of Highly Active Antiretroviral Therapy Initiated during Acute HIV-1 Infection. J Infect Dis. Sep 15;194(6):734-9. Epub 2006 Aug 15. (IF 4.953)

Taubert S & A. Schafberger. Zwischen Forschung und Selbsthilfe – Kompetenznetz HIV/AIDS. Von der Forschung in die Versorgung. in: Von der Forschung in die Versorgung. S.94, HRSG: BMBF, 2006.

Taubert S Kompetenznetz HIV/AIDS. Erste Klinische Studien auf Basis der HIV-Patienten-Kohorte. in: Berater-Info-Brief der DAH Nr. 31, S.3, 2006.

Tschochner M, Schwingel E, Thein C, Wittmann S, Paatz C, Walter H. Superiority of Infectivity-Based over Particle-Based Methods for Quantitation of Drug Resistant HIV-1 as Inocula for Cell Cultures. J. Virol. Methods, 2006. (IF 1.886)

van de Vijver DA, Wensing AM, Angarano G, Asjo B, Balotta C, Boeri E, Camacho R, Chaix ML, Costagliola D, De Luca A, Derdelinckx I, Grossman Z, Hamouda O, Hatzakis A, Hemmer R, Hoepelman A, Horban A, Korn K, Kucherer C, Leitner T, Loveday C, MacRae E, Maljkovic I, de Mendoza C, Meyer L, Nielsen C, Op de Coul EL, Ormaasen V, Paraskevis D, Perrin L, Puchhammer-Stockl E, Ruiz L, Salminen M, Schmit JC, Schneider F, Schuurman R, Soriano V, Stanczak G, Stanojevic M, Vandamme AM, Van Laethem K, Violin M, Wilbe K, Yerly S, Zazzi M, Boucher CA. The calculated genetic barrier for antiretroviral drug resistance substitutionsis largely similar for different HIV-1 subtypes. J Acquir Immune Defic Syndr. 41:352-60, 2006. (IF 1.547)

Vogel M, Lichterfeld M, Kaufmann DE, Mui SK, Altfeld M, Voigt E, Ahlenstiel G, Kupfer B, Walker B, Spengler U, Rockstroh JK. Structured treatment interruptions following immediate initiation of HAART in eight patients with acute HIV-1 seroconversion. Eur J Med Res. Jul 31;11(7):273-8, 2006. (IF 0.994)

Voigt E, Schulz C, Klausen G, Goelz J, Mauss S, Schmutz G, Jessen H, Weitner L, Mutz A, Schranz D, Rockstroh JK, Kaad Study Group. Pegylated interferon alpha-2b plus ribavirin for the treatment of chronic hepatitis C in HIV-coinfected patients. J Infect. Jul;53(1):36-42, 2006. (IF 1.882)

Walker UA, Hoffmann C, Enters M, Thoden J, Behrens G, Mitzel SL. High serum urate in HIV-infected persons - The choice of the antiretroviral matter. AIDS 2006, 20:1556-8, 2006 (IF 5.893)

Walker UA., M. Auclair, D. Lebrecht, M. Kornprobst, J. Capeau and M. Caron. Uridine abrogates the adverse effects of antiretroviral pyrimidine analogues on adipose cell functions. Antiviral Ther. 11: 25-34, 2006. (IF 6.036)

Wieland U, N. Brockmeyer, S. Weissenborn, B. Hochdorfer, M. Stücker, J. Swoboda, P. Altmeyer, H. Pfister, A. Kreuter. Imiquimod treatment of anal intraepithelial neoplasia of HIV-positive men. Archives of Dermatology 142, 2006. (IF 0.740)

Zylka-Menhorn V., Skaletz-Rorowski A, Brockmeyer N.H. Gebündeltes Wissen – KN HIV-AIDA In: Kompetenznetze in der Medizin: von der Forschung in die Versorgung. Schriftenreihe des Bundesministeriums für Bildung und Forschung, 2006.

zurück zur Übersicht zurück zur Übersicht

Publikationen 2005

Ahlenstiel G, Iwan A, Nattermann J, Bueren K, Rockstroh JK, Brackmann HH, Kupfer B, Landt O, Peled A, Sauerbruch T, Spengler U, Woitas RP. Distribution and effects of polymorphic RANTES gene alleles in HIV/HCV coinfection -- a prospective cross-sectional study. World J Gastroenterol. Dec 28;11(48):7631-8, 2005.

Allen TM, Altfeld M, Geer SC, Kalife ET, Moore C, O'sullivan KM, Desouza I, Feeney ME, Eldridge RL, Maier EL, Kaufmann DE, Lahaie MP, Reyor L, Tanzi G, Johnston MN, Brander C, Draenert R, Rockstroh JK, Jessen H, Rosenberg ES, Mallal SA, Walker BD. Selective escape from CD8+ T-cell responses represents a major driving force of human immunodeficiency virus type 1 (HIV-1) sequence diversity and reveals constraints on HIV-1 evolution. J Virol. Nov;79(21):13239-49, 2005. (IF 5.178)

Anneken K., Fischera M., Evers S., Kloska S.,. Husstedt I.W. Recurrent vacuolar myelopathy in HIV infection. J Infect 52: e181-3, 2005. (IF 1.882)

Arasteh K, Gölz J, Marcus U, Rockstroh J, Salzberger B, Vielhaber B. German-Austrian Recommendations for antiretroviral therapy of HIV-infection – partial (current as of December 2004). Update June 2005 [German]. Published at www.daignet.de

Arendt G, Nolting T. [Neurological manifestations of the HIV infection] MMW Fortschr Med. Apr 25;147 Spec No 1:75-7, 2005.

Arendt G. [Neurological manifestations of HIV-infection in the era of highly active antiretroviral therapy (HAART). Fortschr Neurol Psychiatr. Oct;73(10):577-86, 2005. (IF 0.801)

Bäuerle J, J. Mallolas, S. Mauss, M. Laguno, J. Murillas, R. Miquel, G. Schmutz, B. Setzer, JM. Gatell and UA. Walker. MtDNA-depletion in liver tissue of HCV-infected patients - contributing effect of HIV-infection? HIV Medicine 6: 135-139, 2005.

Bäuerle, M., Schmitt-Haendle, M., Taubald, A., Müller, S., Walter, H., Pfeiffer, C., Manger, B., and Harrer, T. Severe HIV-1 encephalitis and development of cerebral non-Hodgkin lymphoma in a patient with persistent strong HIV-1 replication in the brain despite potent HAART -- case report and review of the literature. Eur J Med Res 10, 309-16, 2005. (IF 0.944)

Bocharov, G., Ford, N. J., Edwards, J., Breinig, T., Wain-Hobson, S., and Meyerhans, A. A genetic algorithm approach to simulating HIV evolution reveals the strong impact of multiply infected cells and recombination. J Gen Virol. Nov;86 (Pt 11):3109-18, 2005. (IF 3.013)

Bode H, Lenzner L, Kraemer OH, Kroesen AJ, Bendfeldt K, Schulzke JD, Fromm M, Stoltenburg- Bode H, Lenzner L, Kroesen AJ,  Bendfeldt K, Kraemer OH, Schulzke JD, Zeitz M, Ullrich R. Nelfinavir and Saquinavir induce induce apoptosis in human colon cancer cells. European Journal of Medical Research, Vol 10 / Supplement II, June 1, P128, page 77, 2005.

Brockmeyer NH, Potthoff A, Kasper A, Nabring C, Jockel KH, Siffert W. GNB3 C825T polymorphism and response to anti-retroviral combination therapy in HIV-1-infected patients--a pilot study. Eur J Med Res. 10(11):489-94, 2005. (IF 0.994)

Evers S, Fiori W, Brockmeyer N, Arendt G, Husstedt IW. Recommendations for the coding of neural manifestations of HIV-infections. Nervenarzt. Dec;76 (12):1542, 1544, 1546, 2005. (IF 0.889)

Evers S, W. Fiori, N. Brockmeyer, G. Arendt, I.W. Husstedt. Recommendations for the classification of HIV associated neuromanifestations in the German DRG system. Eur J Med Res; 10(9): 378-380, 2005. (IF 0.944)

Fatkenheuer G, Pozniak AL, Johnson MA, Plettenberg A, Staszewski S, Hoepelman AI, Saag MS, Goebel FD, Rockstroh JK, Dezube BJ, Jenkins TM, Medhurst C, Sullivan JF, Ridgway C, Abel S, James IT, Youle M, van der Ryst E. Efficacy of short-term monotherapy with maraviroc, a new CCR5 antagonist, in patients infected with HIV-1. Nat Med. Nov;11 (11):1170-2, 2005. (IF 28.878)

Franke GH, Hackbarth KP, Potthoff A, Brockmeyer N.  Kompetenznetz HIV/AIDS. Aspects of rehabilitation in HIV and AIDS. Hautarzt. Jul;56 (7):649-58, 2005. (IF 0.535)

Giesen, H.-J. v., Adams, O., Ebel, H., Köller, H., Hefter, H., Arendt, G. Cerebrospinal fluid HIV viral load in different Phases of HIV-associated brain disease. J. Neurol. 252: 801-807, 2005. (IF 2.844)

Harms G, Kunz A, Karcher H, Mugenyi K, Kurowski M. Nevirapine concentration in cervicovaginal and oropharyngeal secretions after single-dose administration to the mother. Antivir Ther,10:777, 2005. (IF 6.036)

Harrer, E. G., Bergmann, S., Eismann, K., Rittmaier, M., Goldwich, A., Müller, S. M., Spriewald, B. M., and Harrer, T. A conserved HLA B13-restricted cytotoxic T lymphocyte epitope in Nef is a dominant epitope in HLA B13-positive HIV-1-infected patients. AIDS 19, 734-5, 2005. (IF 5.835)

Harrer, E., Bauerle, M., Ferstl, B., Chaplin, P., Petzold, B., Mateo, L., Handley, A., Tzatzaris, M., Vollmar, J., Bergmann, S., Rittmaier, M.; Eismann, K; Müller, S. Kalden, J.R., Spriewald, B. Willbold, D., Harrer, T. Therapeutic vaccination of HIV-1-infected patients on HAART with a recombinant HIV-1 nef-expressing MVA: safety, immunogenicity and influence on viral load during treatment interruption. Antivir Ther 10, 285-300, 2005. (IF 2.623)

Harrer, T., Bauerle, M., Bergmann, S., Eismann, K., and Harrer, E. G. Inhibition of HIV-1-specific T-cells and increase of viral load during immunosuppressive treatment in an HIV-1 infected patient with Chlamydia trachomatis induced arthritis. J Clin Virol 34, 224-230. Epub 2005 Sep 2. (IF 2.623)

Julg BD, J R Bogner, A Crispin, F D Goebel Progression of renal impairment under therapy with tenofovir. Aids, v. 19, p. 1332-1333, 2005. (IF 5.835)

Kollan C, Stoll M, Kühne A, Matysiak-Klose D, Puscher J, Hamouda O. Changes within the most currently used regimens of antiretroviral treatment (ART) in the German ClinSurv multicenter cohort [Abstract]. Eur J Med Res; 10 (Suppl II):70, 2005. (IF 0.994)

Kompetenznetz HIV/AIDS. Das Virus hat viele Gesichter. HIV&more 1: 27, 2005.

Kompetenznetz HIV/AIDS. Der durchschnittliche Patient - Demographie und Klinik bei 5080 Infizierten der HIV-Kohorte – Der durchschnittliche Patient. HIV&more 3: 30, 2005.

Kreuter A, N. Brockmeyer, B. Hochdorfer, S.J. Weissenborn, M. Stücker, J. Swoboda, P. Altmeyer, H. Pfister, U. Wieland: Clinical spectrum and virologic characteristics of anal intraepithelial neoplasia in HIV infection. Journal of the American Academy of Dermatology, 52, 603-608, 2005. (IF 2.402)

Kreuter A, N.H. Brockmeyer, H. Pfister, P. Altmeyer, U. Wieland. Human papillomavirus type 26 associated periungual squamous cell carcinoma in situ in a HIV-infected patient with concomitant penile and anal intraepithelial neoplasia. Journal of the American Academy of Dermatology 53, 737-739, 2005. (IF 2.402)

Kreuter A, Ulrike Wieland, Bettina Hochdorfer, Soenke J. Weissenborn, Herbert Pfister, Norbert H. Brockmeyer. Imiquimod is an Effective and Safe Treatment Option for Anal Intraepithelial Neoplasia in HIV-positive Men who have Sex with Men. European Journal of Medical Research 10, Supplement II, 104-105, 2005.

Kupfer B, Ruf T, Matz B, Nattermann J, Spengler U, Rockstroh JK, Brackmann HH, Blumel J, Tacke M, Kaiser R. Comparison of GB virus C, HIV, and HCV infection markers in hemophiliacs exposed to non-inactivated or inactivated factor concentrates. J Clin Virol. Sep;34 (1):42-7, 2005. (IF 2.629)

Lichterfeld M, Haas S, Fischer HP, Voigt E, Rockstroh JK, Spengler U. Liver histopathology in human immunodeficiency virus-hepatitis C virus co-infected patients with fatal liver disease. Gastroenterol Hepatol. May;20 (5):739-45, 2005.

Lichterfeld M, Schmeisser N, Qurishi N, Vogel M, Brackmann HH, Spengler U, Rockstroh JK. Clinical outcomes of HIV-HCV co-infection in a large cohort of hemophiliac patients. J Infect. Apr;50(3):221-8, 2005. (IF 1.882)

Masquelier B, Bhaskaran K, Pillay D, Gifford R, Balestre E, Jorgensen LB, Pedersen C, van der Hoek L, Prins M, Balotta C, Longo B, Kucherer C, Poggensee, Ortiz M, de Mendoza C, Gill J, Fleury H, Porter K; CASCADE Collaboration. Prevalence of transmitted HIV-1 drug resistance and the role of resistance lgorithms: data from seroconverters in the CASCADE collaboration from 1987 to 2003. J Acquir Immune Defic Syndr 40:505-11, 2005. (IF 4.100)

Mehandru S, Tenner-Racz K, Racz P, Markowitz M. The gastrointestinal tract is critical to the pathogenesis of acute HIV-1 infection. J Allergy Clin Immunol. 116:419-22, 2005. (IF 7.667)
Möbius U, Lubach-Ruitman M, Castro-Frenzel B, Stoll M, Esser S, Rockstroh J, Voigt E, Christensen S, Rump A, Behrens GMN, Schmidt RE. Switching to atazanavir improves metabolic disorders in patients with severe hyperlipidemia. J Acquir Immune Defic Syndr; 39:174-180, 2005. (IF 4.100)

Nattermann J, Nischalke HD, Hofmeister V, Kupfer B, Ahlenstiel G, Feldmann G, Rockstroh J, Weiss EH, Sauerbruch T, Spengler U. HIV-1 infection leads to increased HLA-E expression resulting in impaired function of natural killer cells. Antivir Ther.; 10 (1):95-107, 2005. (IF 5.286)

Popovic M, Tenner-Racz K, Pelser C, Stellbrink HJ, van Lunzen J, Lewis G, Kalyanaraman VS, Gallo RC, Racz P. Persistence of HIV-1 structural proteins and glycoproteins in lymph nodes of patients under highly active antiretroviral therapy. Proc Natl Acad Sci USA. 2005,102:14807-12. Epub 2005 Sep 30. (IF 10.231)

Potthoff A., Brockmeyer N.H. Status of HIV-infections. Herz 30(6): 451-7, 2005. (IF 0.952)

Potthoff A., Brockmeyer N.H. Syphilis and HIV infection. Characteristic features of diagnosis, clinical assessment, and treatment. Hautarzt 56(2):133-40, 2005. (IF 0.535)

Rieser S. Zwischenbilanz Medizinischer Kompetenznetze: Es werden Standards gesetzt durch die Besten. Deutsches Ärzteblatt  24: A1710, 2005.

Rockstroh JK, Mocroft A, Soriano V, Tural C, Losso MH, Horban A, Kirk O, Phillips A, Ledergerber B, Lundgren J. EuroSIDA Study Group Influence of hepatitis C virus infection on HIV-1 disease progression and response to highly active antiretroviral therapy. J Infect Dis. Sep 15;192 (6):992-1002, 2005. (IF 1.547)

Salzer U, Chapel HM, Webster AD, Pan-Hammarstrom Q, Schmitt-Graeff A, Schlesier M, Peter HH, Rockstroh JK, Schneider P, Schaffer AA, Hammarstrom L, Grimbacher B. Mutations in TNFRSF13B encoding TACI are associated with common variable immunodeficiency in humans. Nat Genet. Aug; 37(8):820-8, 2005. (IF 25.797)

Scheller C.,. Sopper S, Jenuwein M.,. Neuen-Jacob E, Tatschner T., Grünblatt E., ter Meulen V.,. Riederer P and. Koutsilieri E. Early impairment in dopaminergic neurotransmission in brains of SIV-infected rhesus monkeys due to microglia activation. J Neurochem. 95: 377-87, 2005.

Schmitt-Haendle M.S., Bachmann O., Harrer E., Schmidt B., Bäuerle M., Harrer T. Recognition patterns of HLA-A2-restricted HIV-1-specific CTL in a cohort of HIV-1-infected individuals. Viral Immunology 18, 627-636, 2005. (IF 2.030)

Schofer H., Brockmeyer N., Dissemond J., Effendy I., Esser S., Geiss H.K., Harder S., Hartmann M., Jappe U., Plettenberg A., Reimann H., Shah P., Tschachler E., Wichelhaus T.A., Deutsche Dermatologische Gesellschaft (DDG), Arbeitsgemeinschaft für Dermataologische Infektiologie (ADI). Staphylococcal infections of the skin and mucous membranes. Guideline of the German Dermatologic Society, Study Group of Dermatologic Infectiology. J Dtsch Dermatol Ges 3(9): 726-34, 2005.

Schulbin H, Bode H, Arastéh K, Zeitz M, Ullrich R. ffects of HAART on the gut mucosal cytokine mRNA expression in HIV-infected patients. European Journal of Medical Research, Vol 10 / Supplement II, June 1, P119, page 72, 2005.

Sheldon JA, Corral A, Rodes B, Mauss S, Rockstroh J, Berger F, Schwarze-Zander C, Soriano V. Risk of selecting K65R in antiretroviral-naive HIV-infected individuals with chronic hepatitis B treated with adefovir. AIDS. Nov 18;19(17):2036-8, 2005. (IF 5.835)

Speth C, MP. Dierich and S. Sopper. HIV-infection of the central nervous system: the tightrope walk of innate immunity. Mol Immunol. 42: 213-28, 2005.

Stankov M, Schmidt RE, Behrens GMN. Preadipocyte differentiation determines the susceptibility to stavudine and zidovudine-mediated mitochondrial DNA depletion. Eur J Med Res 10 (suppl II): 37, 2005.

Stankov M, Schmidt RE, Behrens GMN. Zidovudine inhibits adipogenic differentiation of 3T3-L1 cells through inhibition of clonal expansion. Antivir Ther 2005; 10:L20, 2005. (IF 5.286)
Strube F, Bode H, Epple H-J, Schulbin H, Wahnschaffe U, Arastéh K, Zeitz M, Ullrich R. Measurement of tissue HIV load by LightCycler real-time PCR. European Journal of Medical Research, Vol 10 / Supplement II, June 1, P120, page 72, 2005.

Taubert S. Nur 15 % Frauen in bundesdeutscher Kohortenstudie. Wer noch mitmachen will, muss sich beeilen. DHIVA, Dec. 06, S. 16. HRSG: Netzwerk Frauen & AIDS, 2005.
Trapp, S., von Einem, J., Hofmann, H., Köstler, J., Wild, J., Wagner, R., Beer, M. and Nikolaus Osterrieder. Potential of Equine Herpesvirus Type-1 (EHV-1) as a Vector for Immunization. J. Virol. 79:5445-5454, 2005. (IF 5.178)

Venhoff N, M. Zilly, D. Lebrecht, D. Schirmer, H. Klinker, J. Thoden, P. Langmann and UA. Walker. Uridine pharmacokinetics of Mitocnol, a sugar cane extract. AIDS 19: 739-740, 2005. (IF 5.835)

Vogel M, Bieniek B, Jessen H, Schewe CK, Hoffmann C, Baumgarten A, Kroidl A, Bogner JR, Spengler U, Rockstroh JK. Treatment of acute hepatitis C infection in HIV-infected patients: a retrospective analysis of eleven cases. J Viral Hepat. Mar;12 (2):207-11, 2005. (IF 2.550)

Vogel M, Voigt E, Schafer N, Goldmann G, Schwarz N, Kalff JC, Sauerbruch T, Wolff M, Rockstroh JK, Spengler U. Orthotopic liver transplantation in human immunodeficiency virus (HIV)-positive patients: outcome of 7 patients from the Bonn cohort. Liver Transpl. Dec;11(12):1515-21, 2005. (IF 4.447)

von Giesen HJ, Haslinger BA, Rohe S, Koller H, Arendt G. HIV Dementia Scale and psychomotor slowing--the best methods in screening for neuro-AIDS. J Neuropsychiatry Clin Neurosci. Spring;17(2):185-91, 2005. (IF 2.304)

Wensing AM, van de Vijver DA, Angarano G, Asjo B, Balotta C, Boeri E, Camacho R, Chaix ML, Costagliola D, De Luca A, Derdelinckx I, Grossman Z, Hamouda O, Hatzakis A, Hemmer R, Hoepelman A, Horban A, Korn K, Kucherer C, Leitner T, Loveday C, MacRae E, Maljkovic I, de Mendoza C, Meyer L, Nielsen C, Op de Coul EL, Ormaasen V, Paraskevis D, Perrin L, Puchhammer-Stockl E, Ruiz L, Salminen M, Schmit JC, Schneider F, Schuurman R, Soriano V, Stanczak G, Stanojevic M, Vandamme AM, Van Laethem K, Violin M, Wilbe K, Yerly S, Zazzi M, Boucher CA; SPREAD Programme. Prevalence of drug-resistant HIV-1 variants in untreated individuals in Europe: implications for clinical managemen. J Infect Dis. 192:958-66, 2005. (IF 4.943)

Wieland U, Alexander Kreuter, Bettina Hochdorfer, Soenke J. Weissenborn, Arasch Wafaisade, Herbert Pfister, Norbert H. Brockmeyer. Diagnosis and Risk Factors of Anal Human Papillomavirus (HPV) Infection in Human Immunodeficiency Virus (HIV)-positive Men who have Sex with Men (MSM). European Journal of Medical Research 10, Supplement II, 105, 2005.

Woitas RP, Stoschus B, Terjung B, Vogel M, Kupfer B, Brackmann HH, Rockstroh JK, Sauerbruch T, Spengler U. Hepatitis C-associated autoimmunity in patients coinfected with HIV. Liver Int. Dec;25(6):1114-21, 2005. (IF 1.766)

Zylka-Menhorn V. Deutsch-Österreichischer Aids-Kongress: Wenn HIV-Infizierte „in die Jahre kommen“. Deutsches Ärzteblatt 23: A1646-1647, 2005.

Zylka-Menhorn V. Die Patientenkohorte – Das Rückgrat des Kompetenznetzes HIV/AIDS. HIV-Journal 1: 11-13, 2005.

Zylka-Menhorn V. Studienkohorte / Bereits Daten von 5.400 eingeschlossen. HIV&more 2: 33, 2005.

zurück zur Übersicht zurück zur Übersicht

Publikationen 2004

Ahlenstiel G, Woitas RP, Rockstroh J, Spengler U. CC-chemokine receptor 5 (CCR5) in hepatitis C--at the crossroads of the antiviral immune response?.J Antimicrob Chemother. 2004 Jun; 53 (6):895-8.

Bode H, Lenzner L, Kraemer OH, Kroesen AJ, Bendfeldt K, Schulzke JD, Fromm M, Stoltenburg-Didinger G, Zeitz M, Ullrich R. The HIV protease inhibitors saquinavir, ritona-vir, and nelfinavir induce apoptosis and decrease barrier function in human intestinal epithelial cells. Antivir Ther. 2005; 10 (5):645-55.

Brockmeyer N.H., Reiman G., Zylka-Menhorn V. Kompetenznetz HIV/AIDS: Forschen im Verbund. MMW Sonderheft 1: 76-77, 2004.

Brockmeyer N.H., Reiman G., Zylka-Menhorn V. Kompetenznetz HIV/AIDS: Forschungsverbund präsentiert erste Ergebnisse. Der Internist 45: 422-428, 2004. (IF 0.359)

Brockmeyer N.H., Reiman G., Zylka-Menhorn V. Kompetenznezt HIV/AIDS – Realität und Vision. Med Welt“ 55: 156-8, 2004.

Brockmeyer N.H., Reimann G. German Competence Network on HIV/AIDS: Scientific Power by Vertical and Horizontal Cooperation. XV. International AIDS Conference, Bangkok 11.-16.08., 2004.

Brockmeyer NH, Reimann G, Heidelmann U. Off-label-use bei der HIV-Behandlung. Bundesgesundheitsblatt 2003; 46: 875-880.

Brockmeyer NH, Reimann G, Zylka-Menhorn V. Competence Network HIV/AIDS: reality and vision. Med Welt 2004; 55: 156-8.

Brockmeyer NH, Reimann G, Zylka-Menhorn V. First results of the competence network HIV/AIDS. Internist 2004; 45:422-8.

Brockmeyer NH, Reimann G, Zylka-Menhorn V. Kompetenznetz HIV/AIDS, Forschen im Verbund. MMW Fortschr Med 2004, Sonderheft 1: 76-77.

Brockmeyer NH. Competence Network HIV/AIDS: Editorial. Med Welt 2004; 55: 4.

Czub S, M. Czub, E. Koutsilieri, S. Sopper, F. Villinger, J.G. Müller, P. Riederer, V. ter Meulen and G. Gosztonyi. Treatment of SIV-infected macaques with dopaminergic substances aggravates SIV-infection and SIV-associated neuropathology, and induces a multifocal spongiform encephalopathy in pre-AIDS. Acta Neuropath. 107: 216-26, 2004 (IF 2.503)

DAIG Kompetenznetz HIV/AIDS. HIV-Infektion: Die Therapie ist „kniffliger“ geworden. Deutsches Ärzteblatt 28-29: A2022-2023, 2004.

Dunay IR, Heimesaat MM, Bushrab FN, et al. Atovaquone maintenance therapy prevents reactivation of toxoplasmic encephalitis in a murine model of reactivated toxoplasmosis. Antimicrob Agents Chemother,48:4848-4854, 2004. (IF 4.216)

Evers S, A. Rahmann, S. Schwaag, A. Frese, D. Reichelt, I.W. Husstedt. Prevention of AIDS dementia by HAART does not depend on cerebrospinal fluid drug penetrance. AIDS Res Hum Retroviruses; 20(5): 483-491, 2004 (IF 2.375)

Giesen, H.-J. v, Heintges,T., Abassi, N., Kücükköylü, S., Köller, H., Haslinger, B. A., Oette, M., Arendt, G. Influence of Hepatitis C Coinfection on HIV-1-associated psychomotor slowing. JAIDS 35(2): 131-137, 2004.

Giesen, H.-J. v, Jander, S., Köller, H., Arendt, G. Serum and cerebrospinal fluid levels of Interleukin 18 in HIV-1-associated central nervous system disease. J. NeuroVirol. 10: 383-386, 2004 (IF 2.902)

Hahn K, G Arendt, JS Braun, HJ von Giesen, IW Husstedt, M Maschke, ME Straube, E Schielke; German Neuro-AIDS Working Group. A placebo-controlled trial of gabapentin for painful HIV-associated sensory neuropathies. J Neurol. Oct;251(10):1260-6, 2004 (IF 3.140)

Hochdorfer B, Kreuter A, Wieland U, Weissenborn S, Stücker M, Swoboda J, Altmeyer P, Pfister H, Brockmeyer NH. Imiquimod 5% cream for anal intraepithelial neoplasia in HIV infection. JEADV; 18 (Suppl. 1): 164-165, 2004 (IF 1.401)

Hoffmann C, Chow KU, Wolf E, Faetkenheuer G, Stellbrink HJ, Lunzen J, Jaeger H, Stoehr A, Plettenberg A, Wasmuth JC, Rockstroh J, Mosthaf F, Horst HA, Brodt HR. Strong impact of highly active antiretroviral therapy on survival in patients with human immunodeficiency virus-associated Hodgkin's disease. Br J Haematol. 2004 May;125(4):455-62.

Jenuwein M, C. Scheller, E. Neuen-Jacob, S. Sopper, T. Tatschner, V. ter Meulen, P. Riederer, E. Koutsilieri. Dopamine deficits and regulation of the cAMP second messenger system in brains of SIV-infected rhesus monkeys. J Neurovirol. 10: 163-70, 2004 (IF 2.902)

Kreuter A, B. Hochdorfer, M. Stücker, P. Altmeyer, U. Wieland, M.A. Conant, N. H. Brockmeyer. Treatment of anal intraepithelial neoplasia in patients with acquired HIV with imiquimod 5% cream. Journal of the American Academy of Dermatology 50, 980-981, 2004. (IF 2.358)

Kreuter A, U. Wieland, J. Swoboda, H. Pfister, B. Hochdorfer, P. Altmeyer, N. H. Brockmeyer. Anale intraepitheliale Neoplasie und Analkarzinom bei HIV-Infektion – ein zunehmendes Problem?  Retrovirus Bulletin 1, 1-3, 2004.

Kreuter A. et al. Anale intraepitheliale Neoplasie und Analkarzinom bei HIV-Infektion -ein zunehmendes Problem? Retrovirus Bulletin 1: 1-3, 2004.

Lenzner L, Bode H, Krämer O, Loddenkemper C, Kroesen AJ, Schulzke JD, Zeitz M, Ullrich R. Epitheliale Apoptoseinduktion durch die HIV-Proteaseinhibitoren Saquinavir und Nelfinavir in kolorektalen Zelllinien und Tumoren. German Journal of Gastroenterology, 42: 785-944; P137, page 852, 2004.

Mehandru S, Poles MA, Tenner-Racz K, Horowitz A, Hurley A, Hogan C, Boden D, Racz P, Markowitz M. Primary HIV-1 infection is associated with preferential depletion of CD4+ T lymphocytes from effector sites in the gastrointestinal tract. J Exp Med., 200:761-70. Epub 2004 Sep 13 (IF 14.588)

Michel T. M. , J. Thome, D. Martin, K. Nara, S. Zwerina, T. Tatschner, H. G. Weijers and E. Koutsilieri. Cu, Zn- and Mn-superoxide dismutase levels in brains of patients with schizophrenic psychosis. Neural Transm. 111: 1191-201, 2004 (IF 2.628)

Nattermann J, Nischalke HD, Feldmann G, Ahlenstiel G, Sauerbruch T, Spengler U. Binding of HCV E2 to CD81 induces RANTES secretion and internalization of CC chemokine receptor 5.  J Viral Hepat. 2004 Nov;11(6):519-26.

Nischalke HD, Nattermann J, Fischer HP, Sauerbruch T, Spengler U, Dumoulin FL. Semiquantitative analysis of intrahepatic CC-chemokine mRNas in chronic hepatitis C.Mediators. Inflamm. Dec;13 (5-6):357-9, 2004. (IF 1.292)

Rockstroh J., U. Spengler. Aktuelle Aspekte bei der HIV/HCV-Doppelinfektion. Med Welt 55: 166-69, 2004.

Rockstroh JK and Spengler U. HIV and HCV coinfection. Lancet Infect Dis 2004; 4; 437-44.

Scheller C, Ullrich A, McPherson K, et al. CpG oligodeoxynucleotides activate HIV replication in latently infected human T cells. J Biol Chem,279:21897-21902, 2004. (IF 6.355)

Schildgen O, Schewe CK, Vogel M, Daumer M, Kaiser R, Weitner L, Matz B, Rockstroh JK. Successful therapy of hepatitis B with tenofovir in HIV-infected patients failing previous adefovir and lamivudine treatment. AIDS. Nov 19;18(17):2325-7, 2004. (IF 5.835)

Sporer, B., Koedel, U., Eberle, P. R., Arendt, G., Pfister, H.-W. Vascular endothelial growth factor (VEGF) is increased in serum, but not in cerebrospinal fluid in HIV-associated CNS diseases. J. Neurol. Neurosurg. Psychiatry 75: 298-300, 2004 (IF 3.110)

Stocker H, Kruse G, Breske A, et al. A new LC-MS/MS method for the quantitative analysis of T-20 from serum samples and first PK data from patients treated in routine clinical settings. 5th International Workshop on Clinical Pharmacology of HIV Therapy. Rome, Italy, Apr 1-3 2004.

Stocker H, Kruse G, Kreckel P, et al. Nevirapine significantly reduces the levels of racemic methadone and (R)-methadone in human immunodeficiency virus-infected patients. Antimicrob Agents Chemother,48:4148-4153, 2004. (IF 4.216)

Walker U.A. , J. Bäuerle, M. Laguno, J. Murillas, S. Mauss, G. Schmutz, B. Setzer, R. Miquel, JM. Gatell and J. Mallolas. Depletion of mitochondrial DNA in liver under antiretroviral therapy with didanosine, stavudine or zalcitabine. Hepatology 39: 311-317, 2004. (IF 10.416)

Wasmuth JC, Nischalke HD, Jutte A, Fatkenheuer G, Salzberger B, Sauerbruch T, Spengler U, Rockstroh JK, Dumoulin FL. Chemokine mRNA levels in mononucleated cells of HIV-infected patients before and after initiation of PI- versus NNRTI-containing HAART. Antiviral Res. 2004 Mar;61(3):207-12.

Wolf H, R. Wagner, J. Wild, L. Deml, K. Bieler, C. Stahl-Hennig J. Heeney, Y. Shao Entwicklung von HIV-Impfstoffen für Prävention und Therapie. Med Welt 55: 159-65, 2004.

Zylka-Menhorn V. Kompetenznetze in der Medizin – Erste Begutachtungen und neue Mitglieder. Deutsches Ärzteblatt 2002, 48: A3240-A3241.

zurück zur Übersicht zurück zur Übersicht

Publikationen 2003

Arendt G, BA Haslinger. [Neurologic complications of HIV infection in the HAART era. Rapid and efficient diagnosis] MMW Fortschr Med. Apr 28;145 Spec No 1:66-9, 2003.

Arendt G, BA Haslinger. [Psychiatric diseases and HIV infection. These patients are dually stigmatized]. MMW Fortschr Med. Apr 28;145 Spec No 1:70-2, 2003.

Brockmeyer NH, Reimann G, Heidelmann U. Off-label-use bei der HIV-Behandlung. Bundesgesundheitsblatt 2003; 46: 875-880.

Brockmeyer NH, Reimann G, Zylka-Menhorn V. HIV/AIDS Competence Network. An example for research networking in Germany. Internist 2003 44:694-8, 700.

Brockmeyer NH. Deutsch-Österreichische Leitlinien für Diagnostik und Therapie Dtsch Med Wochenschr 2003 S1: 5-6.

Deutsche AIDS-Gesellschaft und Österreichische AIDS-Gesellschaft, Kompetenznetz HIV/AIDS. Deutsch-Österreichische Leitlinien zur antiretroviralen Therapie der HIV-Infektion. Dtsch Med Wochenschr 2003; S1: 7-18.

Deutsche AIDS-Gesellschaft und Österreichische AIDS-Gesellschaft, Deutsch-Österreichische Leitlinien zur Diagnostik und Behandlung HIV-diskordanter Paare mit Kinderwunsch. Dtsch Med Wochenschr 2003; S1: 32-35.

Deutsche AIDS-Gesellschaft und Österreichische AIDS-Gesellschaft, Kompetenznetz HIV/AIDS. Deutsch-Österreichische Leitlinien zur HIV-Therapie in der Schwangerschaft. Dtsch Med Wochenschr 2003; S1: 19-31.

Deutsche AIDS-Gesellschaft und Österreichische AIDS-Gesellschaft, Kompetenznetz HIV/AIDS. Deutsch-Österreichische Leitlinien zur postexpositionellen Prophylaxe der HIV-Infektion. Dtsch Med Wochenschr 2003; S1: 36-50.

Kreuter, G. Reimann, S. Esser, H. Rasokat, M. Hartmann, J. Swoboda, MA. Conant, E. Tschachler, K. Arasteh, P. Altmeyer, NH. Brockmeyer. Screening and therapy of anal intraepithelial neoplasia (AIN) and anal carcinoma in patients with HIV-infection. Dtsch Med Wochenschr. 19: 128(38):1957-62, 2003. (IF 0.552)

Lichterfeld M, Nischalke HD, van Lunzen J, Söhne J, Woitas R, Sauerbruch T, Rockstroh J, Spengler U. The tandem-repeat polymorphism of the DC-SIGNR gene does not affect susceptibility to HIV infection and the progression to AIDS. Clin Immunol 2003;107: 55-59.

Lichterfeld M, Wöhrmann A, Schmeisser N, Fätkenheuer G, Salzberger B, Wyen C, Schmitz K, Sauerbruch T, Rockstroh JK. Superior virological efficacy of ritonavir-boosted protease inhibitor regimens compared to single protease inhibitor therapy. Eur J Med Res 2003; 8:56-60.

Meyerhans, A., Jung, A., Maier, R., Vartanian, J.-P., Bocharov, G., and Wain-Hobson, S. The non-clonal and transitory nature of HIV in vivo. Swiss Medical Weekly 133, 451-454, 2003. (IF 1.162)

Nattermann J, Nischalke HD, Kupfer B, Rockstroh J, Hess L, Sauerbruch T, Spengler U. Regulation of CC-chemokine receptor 5 in hepatitis G virus infection. AIDS 2003; 17:1457-1462.

Quirishi N, Kreuzberg C, Lüchters G, Effenberger W, Kupfer B, Sauerbruch T, Rockstroh J, Spengler U.  Effect of antiretroviral therapy on liver-related mortality in patients with HIV and hepatitis C coinfectio. Lancet 2003; 362: 1708-13.

Scheller C, S. Sopper, E. Koutsilieri, S. Ludwig, V. ter Meulen, C. Jassoy. Caspase inhibitors as a supplement in immune activation therapies to achieve eradication of HIV in its latent reservoirs. Ann. NY Acad. Sci. 1010: 209-12, 2003. (IF 1.892)

Schulbin H, Bode H, 1.042 T, et al. Mucosale mRNA-Zytokinexpression bei HIV-infizierten Patienten vor und 4 Monate unter HAART. Infection,31, Suppl. I:87-88, 2003. (IF 1.042)

Schulbin H, Bode H, Wahnschaffe U, et al. Mukosale mRNA-Zytokinexpression von HIV-Patienten bei Initiierung und im Verlauf einer HAART. Eur J Med Res,8, Suppl. I:85, 2003. (IF 1.100)

Sopper S, D. Nierwetberg, A. Halbach, U. Sauer, C. Scheller, C. Stahl-Hennig, K. Mätz-Rensing, F. Schäfer, T. Schneider, V. ter Meulen and J.G. Müller. Impact of simian immunodeficiency virus (SIV) infection on lymphocyte numbers and T-cell turnover in different organs of rhesus monkeys. Blood. 101: 1213-1219, 2003. (IF 10.120)

Tschochner M. Resistenz in der HIV-Therapie-Diagnostik und Management; Mark Oette, Rolf Kaiser und Dieter Häusinger, 1. Auflage – Bremen: UNI-MED, chapter 3.3, 2003.

von Giesen HJ, H Koller, D de Nocker, BA Haslinger, G Arendt. Long-term safety and efficacy of NNRTI within the central nervous system. HIV Clin Trials. Nov-Dec;4 (6):382-90, 2003.

Wain-Hobson, S., Renoux-Elbé, C., Vartanian, J.-P., and Meyerhans A. Network analysis of HIV/SIV sequence sets reveals massive recombination resulting in shorter pathways. J. Gen. Virol. 84, 885-895, 2003. (IF 3.036)

zurück zur Übersicht zurück zur Übersicht

Publikationen 2002

Deutsche AIDS-Gesellschaft (DAIG) and Österreichische AIDS-Gesellschaft, Kompetenznetz HIV/AIDS. Post-exposure prophylaxis of HIV infection – German-Austrian Recommendations. Eur J Med Res 2002, 7:509-527.

Jung, A., Maier, R., Vartanian, J-P., Bocharov, G., Jung, V., Fischer, U., Meese, E., Wain-Hobson, S., and Meyerhans, A. Recombination: Multiply infected spleen cells in HIV patients. Nature 418, (2002) 144 (IF 30.432)

Walter H, Low P, Harrer T, Schmitt M, Schwingel E, Tschochner M, Helm M, Korn K, Ueberla K, Schmidt B. No evidence for persistence of multidrug-resistant viral strains after a 7-month treatment interruption in an HIV-1-infected individual J Acquir Immune Defic Syndr. 31(2):137-46, 2002.

Zylka-Menhorn V. Kompetenznetze in der Medizin – Erste Begutachtungen und neue Mitglieder. Deutsches Ärzteblatt 2002, 48: A3240-A3241.

zurück zur Übersicht zurück zur Übersicht

Abstracts 2010

Arendt G. et al. HIV-associated-dementia (HAD) – pathomechanisms in different stages of the infection. Conference on Retroviruses & Opportunistic Infections (CROI), Feb. 16-19th 2010, San Francisco.

Brockmeyer NH, Wyen C. Suszeptibilität des Patienten mit HIV-Infektion als begrenzender Faktor für die Toxizität der Behandlung mit Efavirenz – die KompNet-Gen Tox-Studie sowie Studiendaten aus der Kohorte des Kompetenznetzes HIV/AIDS. 116. Internistenkongress DGIM, April 2010.

Brunne V. The Competence Network for HIV/AIDS from a health systems perspective: towards an impact assessment. 5. Ger.-Jap. HIV-Symposium, Tokyo, May, 9.-12th, 2010.

Burruano L. HIV/AIDS infection in Ukraine: a review of epidemiological data. Retrovirology 2010, 7(Suppl 1):P1. 16th International Symposium on HIV and Emerging Infectious Diseases. 24.-26 March 2010, Marseille, France. (PDF,172KB)

Etschel J, Maurer K, Hofmann C, Eismann K, Dörrie J, Schaft N, Müller S, Harrer T. mRNA electroporation of PBMC is a rapid and efficient method for immunomonitoring of T-cell responses against autologous HIV-1 strains. World AIDS Conference, 18.-23. July, Vienna, 2010.

Harrer T. HIV-specific T-cells and Immunotherapy of HIV-1 infection. 5. Ger.-Jap. HIV-Symposium, Tokyo, May, 9.-12th 2010.

Harrer T. Analysis of immune selection as a potential cause for the presence of CS mutation 431V in treatment-naïve HIV-1 isolates. World AIDS Conference, 18.-23. July, Vienna, 2010.

Hückelhoven A, Bergmann S, Eismann K, Müller S, Etschel J, Harrer E, Harrer T. Analysis of HIV-1-specific CTL cross-reacting with Influenza A virus in a cohort of HIV-1-infected patients. World AIDS Conference, 18.-23. July Vienna, 2010.

Hückelhoven A, Bergmann S, Eismann K, Müller S, Etschel J, Harrer E, Harrer T. RNA transfection of T cells with HIV-specific TCR, to obtain T cells recognizing HIV-epitopes. World AIDS Conference, 18.-23. July Vienna, 2010.

Jansen K, Brockmeyer N.H. Combined Epidemiology, Prevention and Behavioural Surveillance – a Methodological Step to a Sustained Reduction of HIV Prevalence. 5. Ger.-Jap. HIV-Symposium, Tokyo, May, 9.-12th, 2010.

Jansen K. Impact of sex on concomitant diseases of HIV-positive persons (PLWHA) in Germany - A comparison on basis of the KompNet cohort. 5. Ger.-Jap. HIV-Symposium, Tokyo, May, 9.-12th 2010.

Jansen K. Worse clinical outcomes of HIV-positive patients (PLWHA) with lower income level -Results of an analysis on basis of the KompNet cohort. 5. Ger.-Jap. HIV-Symposium, Tokyo, May, 9.-12th 2010.

Jansen K, Brockmeyer NH, Dlugay V, Stoll M, Volkert R, Gölz J, Buhk T, Carganico A, Kreckel P, Müller M, Skaletz-Rorowski A, Mertens V, Michalik C, and the Competence Network for HIV/AIDS. Higher probability of lower income in HIV-positive patients (PLWHA) having poorer clinical outcomes: results of an analysis on basis of the KompNet cohort. 18th International AIDS Conference 2010, Vienna, 18.-23.7.2010.

Jansen K., Sönnerborg A, Pugliese P, Biguenet S, Eychenne S.-L., Brockmeyer NH, Michalik C, Dupke S, Jaeger H, Plettenberg A, Butcher D, Jiménez-Expósito MJ, and Competence Network for HIV/AIDS. Long-Term Efficacy and Safety of Atazanavir/Ritonavir Treatment in a Real-Life Cohort of Treatment-Experienced HIV patients. Tenth International Congress on Drug Therapy in HIV Infection 2010, Glasgow, November 2010. (Poster P031, PDF 897KB)

Krznaric et al. Retrospektive Analyse über den Zeitpunkt des Therapiebeginns und die Zusammenstellung der Therapieschemata bei HIV-positiven Frauen seit 1995. KIT - 10. Kongress für Infektionskrankheiten und Tropenmedizin, Köln, 06.06.2010.

Liptrott N, Pushpakom S, Wyen C, Rockstroh J, Mauss S, Knechten H, Brockmeyer NH, Hopper-Borge E, Back D, Owen A, and German Competence Network for HIV/AIDS. Association of ABCC10 polymorphisms with nevirapine plasma concentrations in the German Competence Net for HIV/AIDS. Conference on Retroviruses & Opportunistic Infections (CROI), San Francisco, 16.-19.2.2010.

Merz R. Art Therapy: Right here, right now - the way to the future starts with the first Stepps. World AIDS Conference, 18.-23. Juli, Vienna 2010.

Müller S, Harrer T. Analysis of immune selection as a potential cause for the presence of CS mutation 431V in treatment-naïve HIV-1 isolates. World AIDS Conference, 18.-23. Juli, Vienna 2010.

Nitschke H, Brockmeyer N.H, Bunte A. Schnelltests für sexuell übertragbare Erkrankungen – Chancen und Risiken. Deutscher STD-Kongress, 9.-10.09.2010, Memmingen. (accepted)

Plettenberg et al. Impact of timing HAART-initiation on immune status and clinical course in the cohort of the German Competence Network for HIV/AIDS. 13. Münchener AIDS-Tage, 3.-6. März 2010, München.

Plettenberg et al. Impact of timing HAART-initiation on immune status and clinical course in the patient cohort of the Competence Network for HIV/AIDS. KIT - 10. Kongress für Infektionskrankheiten und Tropenmedizin, 23.-26. Juni, Köln.

Potthoff A. Syphilis treatment in HIV positive patients. 5. Ger.-Jap. HIV-Symposium, Tokyo, May, 9.-12th, 2010.

Skaletz-Rorowski A. Quo vadis Kompetenznetz HIV/AIDS? 5. Würzburger Infektiologisches Symposium, Mai 2010.

Sopper S. Microbial translocation is not the cause of chronic immune activation and disease progression in SIV-infected macaques. 5. Ger.-Jap. HIV-Symposium, Tokyo, May, 9.-12th, 2010.

Taubert S. HIV und Ethik: Angesteckt – Selber schuld? Verantwortung und Schuldkonzepte im Kontext der HIV-Infektion. HIV and Ethics: Infected – Your own fault? Responsibility and concepts of guiltiness in context of HIV/AIDS. 13. Münchener AIDS-Tage, 3.-6. März 2010, München.

Wolf H. European HIV-vaccine projects – present and future. 5. Ger.-Jap. HIV-Symposium, Tokyo, May, 9.-12th, 2010.

Wyen C. et al. Association of ABCC10 polymorphisms with nevirapine plasma concentrations in the German Competence Net for HIV/AIDS. Conference on Retroviruses & Opportunistic Infections (CROI), Feb. 16-19th 2010, San Francisco.

Wyen C. et al. A novel application of population pharmacokinetic analysis: simulating the impact of CYP2B6 516G>T for 400mg of nevirapine dosing. Conference on Retroviruses & Opportunistic Infections (CROI), Feb. 16-19th 2010, San Francisco.

zurück zur Übersicht zurück zur Übersicht

Abstracts 2009

Jansen K, Brockmeyer NH, Baudewig M, Walli R, Haastert B, Freiwald M, Harrer T, Staszewski S, Kuhlmann B, Mosthaf F, Schmidt RE, Scholten S, Skaletz-Rorowski A, Esser S, Michalik C, and the Competence Network for HIV/AIDS. Concomitant diseases of HIV-positive persons (PLWHA) in Germany – a comparison between sexes on basis of the KompNet cohort. EACS 2009, 11.-14.11.2009, Köln, Germany

Jansen K, Brockmeyer NH, Dlugay V, Stoll M, Volkert R, Gölz J, Buhk T, Carganico A, Kreckerl  P, Müller M, Skaletz-Rorowski A, Mertens V, Michalik C, and the Competence Network for HIV/AIDS. Poorer clinical outcomes of HIV-positive patients (PLWHA) having lower income: results of an analysis on basis of the KompNet cohort. EACS 2009, 11.-14.11.2009, Köln, Germany

Potthoff A., Brockmeyer N.H. Rapamycin treatment in classic Kaposi´s sarcoma with leg ulcers. ADO Jahrestagung, 24.-26.09.2009, Köln, Germany

Jin C., Feng L., Potthoff A., Hoxtermann S., Brockmeyer N.H., Wu N. CD8+T cells activation is down regulated lower than normal in AIDS patients receiving long term effective antiviral therapy. Deutscher STD-Kongress, 17.-19.09.2009, Bochum

Potthoff A., Brockmeyer N.H. Rapamycin treatment in classic Kaposi´s sarcoma with leg ulcers. Deutscher STD-Kongress, 17-19.09.2009, Bochum

Brockmeyer N.H., Gingelmaier A., Haberl A., Jansen K., Michalik C. (2009). Das Schwangerenmodul im Kompetenznetz HIV/AIDS - Ziele, Strukturen, Methoden und Ansprechpartner. 9. Fachtagung HIV und Schwangerschaft, 30./31.01.2009, Wiesbaden, Poster

Brockmeyer N.H. CompNet HIV/AIDS – successful networking in Germany and Europe. 4. Japansymposium, 23./24.03.2009 in Bochum, Deutschland, Poster

Burruano L, Kruglov Y. HIV/AIDS among women in Eastern Europe: Recent developments in the Russian Federation and the Ukraine. 5th European Conference on Clinical and Social Research on AIDS and Drugs, 28.-30. April 2009, Vilnuis, Litauen, Poster

Jansen K, Brockmeyer NH, Skaletz-Rorowski A, Werner F, Michalik C. Die nationale HIV-Patientenkohorte:  Forschungsinstrument für eine optimierte und evidenzbasierte Versorgung HIV-positiver Patienten in Deutschland. Jubiläumsveranstaltung der Kompetenznetze Deutschland und der TMF 11./12. Juni 2009 in Berlin, Poster

Skaletz-Rorowski A, Jansen K, Werner F, Brockmeyer NH. Kompetenznetz HIV/AIDS: national verankert – international vernetzt. Jubiläumsveranstaltung der Kompetenznetze Deutschland und der TMF 11./12. Juni 2009 in Berlin, Poster

Drewes J., Langer P. C., und das Kompetenznetz HIV/Aids. Die Rolle der Postexpositions-Prophylaxe in der Prävention mit MSM: Ergebnisse einer Befragung von HIV-Schwerpunktärzten. SÖDAK 2009, 24. – 27. Juni 2009, St. Gallen, Schweiz

Jansen K., Brockmeyer N. H., Haastert B., Baumgarten A., Stoehr A., Behrens G., Jaeger H., Hartl H., Mutz A., Skaletz-Rorowski A., Esser S., Michalik C. and the Competence Network for HIV/AIDS. Do patients treated by outpatient clinics or by private practitioners face differing treatment characteristics and clinical outcomes in Germany? SÖDAK 2009, 24. – 27. Juni 2009, St. Gallen, Schweiz
Nähere Informationen s. Abstract (PDF, 11KB)

Jansen K., Brockmeyer N., Dlugay V., Stoll M., Volkert R., Gölz J., Buhk T., Carganico A., Kreckel P., Müller M., Skaletz-Rorowski A., Mertens V., Michalik C.  and the Competence Network for HIV/AIDS. Clinical outcomes of HIV-positive patients (PLWHA) having different income status: Results of an analysis on basis of the KompNet cohort. SÖDAK 2009, 24. – 27. Juni 2009, St. Gallen, Schweiz
Nähere Informationen s. Abstract (PDF, 74KB), Vortrag (PDF, 171KB)

Jansen K., Brockmeyer N. H., Baudewig M., Walli R., Haastert B., Freiwald M., Harrer T., Staszewski S., Kuhlmann B., Mosthaf F., Schmidt R. E., Scholten S., Skaletz-Rorowski A., Esser S., Michalik C. and the Competence Network for HIV/AIDS. Concomitant diseases of HIV-positive persons (PLWHA) in Germany – a comparison between sexes on basis of the KompNet cohort. SÖDAK 2009, 24. – 27. Juni 2009, St. Gallen, Schweiz
Nähere Informationen s. Abstract (PDF, 12KB), Poster (PDF, 134KB)

Stoll M, Mertens V, Michalik C, Jansen K, Brockmeyer NH, Jäger H, Plettenberg A, Moll A, Dupke S, Köppe S, Schmidt RE, Kompetenznetz HIV/AIDS. Optimierung einer zielgerichteten, subsidiären Einzelhilfe durch die Deutsche AIDS Stiftung (DAS) durch eine Vernetzung mit Daten aus dem Kompetenznetz HIV/AIDS. SÖDAK 2009, 24. – 27.06.2009, St. Gallen, Schweiz

Jansen K., C. Michalik, B. Haastert, H. Jager, A. Plettenberg, A. Moll, S. Dupke, S. Esser, S. Koppe, R. Schmidt, N. H. Brockmeyer and the Competence Network for HIV/AIDS. Do patients treated by outpatient clinics or by private practitioners face differing treatment characteristics and clinical outcomes in Germany? 4. Japansymposium, 23./24.03.2009 in Bochum, Poster (PDF, 207KB)

Marcus U., Michalik C., Brockmeyer N. H., Duglay V., Zeitz M., Lauenroth-Mai E., Hower M., Reuter S., Stellbrink H.-J., Rieke A., Ulmer A., Jansen K. and the Competence Network for HIV/AIDS. Late and Early Presenters in the German KompNet Cohort – a comparison of sociodemographic variables. SÖDAK 2009, 24. – 27. Juni 2009, St. Gallen, Schweiz
Nähere Informationen s. Abstract (PDF, 12KB), Poster (PDF, 119KB)

Maurer Katja, Jan Schmökel, Frank Kirchhoff, Jennifer Etschel, Sascha Antoni, Kathrin Eismann, Silke Bergmann, Pia Rauch, Karin Metzner, Angela Hückelhoven1, Sandra M. Müller, Ellen G. Harrer, Thomas Harrer, German Competence Network for HIV/AIDS. Association of Effective Control of HIV-1 with Strong CTL Selection Pressure and a Highly Mutated Nef in a HIV-1-Infected Patient. 4. Japansymposium, 23./24.03.2009 in Bochum, Deutschland, Poster

Merz R., Brockmeyer N.H., Aldridge D. und das Kompetenznetz HIV/AIDS. Ergebnisse einer kunsttherapeutischen Studie. SÖDAK 2009, 24. – 27. Juni 2009, St. Gallen, Schweiz

Nübling M., Lincke H.-J., Donatz V., Mühlbacher A. und das Kompetenznetz HIV. Ermittlung von Patientenpräferenzen bei der Therapie von HIV/AIDS. SÖDAK 2009, 24. – 27. Juni 2009, St. Gallen, Schweiz
Potthoff A., Jansen K., Doerler M., Michalik C., Brockmeyer N H. for the Network of Competence HIV/AIDS. High risk of mamma carcinoma in HIV infected men? SÖDAK 2009, 24. – 27. Juni 2009, St. Gallen, Schweiz

Potthoff A., Kreuter A., Brockmeyer N.H. and Competence Network for HIV/AIDS. Streptococcal proctitis resembling gonorrhoea in HIV infected men who have sex with men. SÖDAK 2009, 24. – 27. Juni 2009, St. Gallen, Schweiz

Potthoff A, Kreuter A, Brockmeyer NH and Competence Network for HIV/AIDS. Anal streptococcal proctitis in HIV infected men who have sex with men. 4. Japansymposium, 23./24.03.2009 in Bochum, Deutschland, Poster

Potthoff A, Brockmeyer NH, Competence Network for HIV/AIDS Germany. Treating syphilis in HIV infected patients. 4. Japansymposium, 23./24.03.2009 in Bochum, Deutschland, Poster

Stoll M., Brockmeyer N., Rockstroh J., Kompetenznetz HIV/AIDS, Deutsche AIDS Gesellschaft. Kostenrisiken einer spezialisierten klinischen Infektiologie durch Fallpauschalen (Morbi-RSA und G-DRG). SÖDAK 2009, 24. – 27. Juni 2009, St. Gallen, Schweiz

Wolf A., Loss J., Taubert S. Erwartungen an den Arzt – optimale HIV/STD-Prävention aus der Sicht schwuler Männer. SÖDAK 2009, 24. – 27. Juni 2009, St. Gallen, Schweiz

zurück zur Übersicht zurück zur Übersicht

Abstracts 2008

Brockmeyer N.H., Potthoff A. (2008) HIV associated tumors. 17th Congress of European Academy of Dermatology and Venereology, abstract No. 0237, 17.bis 21.09.2008, Paris, France

Potthoff A, Eberlein J, Brockmeyer NH und Competence Network HIV/AIDS. Treatment of cutaneous warts in HIV-infected patients. EADV 2008, Poster

Potthoff A, Kreuter A, Brockmeyer NH, Kompetenznetz HIV / AIDS. Anale Ulzeration-Benigne oder maligne? ADO 2008, Poster

Wieland U, Brockmeyer NH, Pfister H, Kreuter A, für das Kompetenznetz HIV/AIDS. Papilllomvirus-induzierte Dysplasien des Penis bei HIV-positiven Männern. Münchner AIDS-Tage, 13.-16.03.2008 in Berlin

zurück zur Übersicht zurück zur Übersicht

Abstracts 2007

Arendt G; Nolting T; Husstedt I-W; Koutsilieri E; Maschke M; Obermann M; Sopper S; Riederer P; ter Meulen V; Kompetenznetz HIV/AIDS. Muster neuropsychologischer Defizite bei klinisch asymptomatischen, HIV-1-positiven Patienten. 3. Deutsch-Oesterreichischer AIDS-Kongress 2007, 27.-30.06.2007, Frankfurt am Main, Germany, B.11, Oral presentation. European Journal of Medical Research; 12 (Suppl II): 56

Balogh A; Mueck B; Wolf E; Koegl C; Jaegel-Guedes E; Jaeger H. Therapieunterschiede bei HIVinfizierten Frauen und Männern in einer monozentrischen deutschen HIV-Kohorte. 3. Deutsch-Oesterreichischer AIDS-Kongress 2007, 27.-30.06.2007, Frankfurt am Main, Germany, B.29, Poster. European Journal of Medical Research; 12 (Suppl II): 63-4

Bartmeyer B; Fleischhauer C;  Kuecherer C; Kollan C; Poggensee G; Hamouda O for the German Seroconverter study group. Epidemiological up-date of transmission of resistant HIV-strains in patients with a documented date of infection in the German seroconverter cohort (1997-2006). 5th European HIV drug resistance workshop 28-30.03.2007, Cascais, Portugal (Poster)

Bauer Asli; Frank Notka; Marcus Graf; J Wild and R Wagner. Improvement of Vaccines by Influencing Transgene Expression via intragenic CpG Dinucleotides ESGT Conference Rotterdam, 2007

Behrens GMN; Wittke S; Luecke T; Das A; Moebius U; Mischak H; Schmidt RE; German Competence Network HIV/AIDS. Tubular amino acid reabsorption and urinary proteome analysis in HIV patients treated with antiretroviral therapy. Oral Presentation on the 4th IAS Conference on Pathogenesis, Treatment and Prevention, Sydney, 22-25 July 2007,  EAB304

Bieler Kurt; Lydia Pitzschler; J Wild; Hans Wolf and R Wagner. 2nd Generation of Sequence-Modified gagpolnef DNA Vaccines DNA Vaccines Malaga, Poster

Brockmeyer N; Kreuter A; Pfister H; Altmeyer P; Wieland U. Elevated anal HPV16-DNA loads in HIV-positive men who smoke. 14th Conference on Retroviruses and Opportunistic Infections, 25.-28.02.07, Los Angeles, USA, Poster abstract 872, pp 404

Brockmeyer NH; Racz P; Wieland U; Jäger H; Jägel-Guedes E. Competence Network for HIV/AIDS – a competent partner for HIV/AIDS research 3rd European Congress of Virology, 01.-05.09.07, Nürnberg, Germany

Buchholz B; Wintergerst U; Brockmeyer NH; Competence Network for HIV/AIDS; MITOC. European Study about mitochondrial toxicitiy in HIV-negative children born to HIV-1 infected mothers (MITOC). 3. Deutsch-Oesterrischer AIDSKongress 2007, 27.-30.06.2007, Frankfurt am Main, Germany, B.ER.8, Oral presentation, invited. European Journal of Medical Research; 12 (Suppl II): 15

Donhauser N; Helm M; Schuster P; Vollmer J; Schmidt B. Optimized class C oligodeoxynucleotides (ODN) support the impaired innate immune response of plasmacytoid dendritic cells (PDC) in HIV-infected patients. 3. Deutsch-Oesterreichischer AIDS-Kongress 2007, 27.-30.06.2007, Frankfurt am Main, Germany, F.5, oral presentation. European Journal of Medical Research; 12 (Suppl II): 121-2

Donhauser N; Helm M, Schuster P, Vollmer J, Schmidt B. Optimized C-Class CpG oligodeoxynucleotides (ODN) enhance the impaired innate immune response of plasmacytoid dendritic cells (PDC) in HIV-infected patients. 3rd European Congress of Virology, 01.-05.09.07, Nürnberg, Germany

Graf M; LudwigC; Kehlenbeck S; Jungert K; Wagner R. A quasi-lentiviral green fluorescent protein reporter exhibits nuclear export features of late human immunodeficiency virus type 1 transcripts. ESGT Conference, Rotterdam, 2007

Harrer T; Hain J; Meyer T; Baedecker N; Sobek V; Baeuerle M; Jaeger H; Helm M; Schneider L; Gorriahn D; Harrer EG; German Competence Network on HIV/AIDS. A  randomized, controlled, phase II study with an MVA-nef vaccine in HIV-1 infected patients followed by Structured Treatment Interruption (STI) 11th European AIDS Conference / EACS, 24-27 October 2007, Madrid, Spain

Kaup B; Schlottmann R; Ellrichmann GG; Ellrichman M; Banasch M; Potthoff A; Brockmeyer NH; Schmidt W. Polymyositis – differential diagnosis in HIV-associated myopahtie. 3. Deutsch-Oesterrischer AIDSKongress 2007, 27.-30.06.2007,Frankfurt am Main, Germany, B20, Poster. European Journal of Medical Research; 12 (Suppl II): 60

Körner C; Schulte D; Nischalke H-D; Nattermann J; Spengler U; Rockstroh JK, Investigation of CD4+ T cell apoptosis rates in HIV- and HIV/HCV-coinfected patients treated with a highly active antiretroviral therapy (HAART). 3. Deutsch-Oesterreichischer AIDS-Kongress 2007, 27.-30.06.2007, Frankfurt am Main, Germany, C11, oral presentation. European Journal of Medical Research; 12 (Suppl II): 74

Körner C; Schulte D; Nischalke H.-D.; Nattermann J.; Spengler U.; Rockstroh J.K. Investigation of CD4+ T cell apoptosis rates in HIV- and HIV/HCV co-infected patients treated with a highly active antiretroviral therapy (HAART), 11th European AIDS Conference / EACS, 24-27 October 2007, Madrid, Spain

Köstler J; Hofmann H; Boeckl K; Tischer K; Osterrieder N; Wild J; Wagner R. HIV Vaccine Candidates in Cross-Validation on Dendritic Cells. 3. Deutsch-Oesterreichischer AIDS-Kongress 2007; 27.-30.06.2007, Frankfurt am Main, Germany, poster. European Journal of Medical Research; 12 (Suppl II): 129

Kosovac D; Lütschg V; Wild J and Wagner R. Sequence dependent activation of innate immune system by plasmid DNA in a TLR9 dependent and independent manner. 3. Deutsch-Oesterreichischer AIDS-Kongress 2007, 27.-30.06.2007, Frankfurt am Main, Germany, poster. European Journal of Medical Research; 12 (Suppl II): 122

Kremer H; Sonnenberg-Schwan U; Arendt G; Brockmeyer N; Ulmer A; Gräfe K; Starke W HIV or ART? Gender differences in the causal attribution of symptoms and adverse events. 3. Deutsch-Oesterreichischer AIDS-Kongress 2007, 27.-30.06.2007, Frankfurt am Main, Germany, D45. European Journal of Medical Research; 12(Suppl II): 97

Kremer H; Sonnenberg-Schwan U; et al. Gender differences on demographics, disease stage, antiretroviral therapy, and response to therapy in the cohort of the German Competence Network HIV/AIDS. 3. Deutsch-Oesterreichischer AIDS-Kongress 2007, 27.-30.06.2007, Frankfurt am Main, Germany, B31, oral presentation. European Journal of Medical Research; 12(Suppl II): 64

Kremer H; Steffan E Barriers and motivators to participation of women living with HIV in clinical trials and research studies. 3. Deutsch-Oesterreichischer AIDS-Kongress 2007; 27.-30.06.2007, Frankfurt am Main, Germany, A.ER.25, oral presentation invited. European Journal of Medical Research; 12 (Suppl II): 8

Kuecherer C; Poggensee G; Bartmeyer B; Somogyi S; Fleischhauer C; Korn K; Dupke S; Cordes C; Jessen H; Klausen G; Hamouda O; for the HIV/AIDS competence network. Trends in transmission of drugresistant HIV strains between 1996-2005 in Germany. 2nd International Workshop on HIV Transmission, 26-28.08.2007, Washington, USA

Kuecherer C; Bartmeyer B; Somogyi S and Hamouda O. Transmission of resistant HIV in Germany. Russian-German Conference of the Koch-Metchnikov-Forum "Tuberculosis, HIV/AIDS, viral hepatitis, problems of blood safety and health care management". Tomsk, Sibirien 9-12.09.2007

Kuecherer C; Poggensee G; Bartmeyer B; Somogyi S; Fleischhauer C; Korn K; Dupke S; Cordes C; Jessen H; Klausen G; Hamouda O; German HIV-1 Seroconverter Study Group. Trends in the transmission of drug-resistant HIV strains: Increas of NNRTI resistance accompanied by a decrease ofNRTI resistance (German HIV-1 seroconverterstudy). 3. Deutsch-Oesterreichischer AIDS-Kongress 2007, 27.-30.06.2007, Frankfurt am Main, Germany, oral presentation, 2007. European Journal of Medical Research; 12 (Suppl II): 21

Lebrecht D., YA. Vargas-Infante, B. Setzer, J. Kirschner and UA. Walker. Uridine supplementation antagonizes zalcitabine-induced microvesicular steatohepatitis in mice. Jan;45(1):72-9.IF 9.792

Leikam Doris; Frank Notka and R Wagner. Improving DNA based therapeutics and vaccines by adapting intragenic CpG content. DNA Vaccines Malaga, 2007

Meiser F; C Scheller; E Neuen-Jacob; S Sopper; D Vosswinkel; V terMeulen; E Koutsilieri for the German Competence Network HIV/AIDS. Neurodysfunction in immmunodefeiciency virus-infected subjects is due to disruption of the glutamatergic synapse. 3. Deutsch-Oesterreichischer AIDS-Kongress 2007, 27.-30.06.2007, Frankfurt am Main, Germany, B12, oral presentation. European Journal of Medical Research; 12 (Suppl II): 56

Michalik C; Theisen D; Skoetz N; Brenner M; Paulus U; Kompetenznetz HIV/AIDS. Maßnahmen und Empfehlungen zur Qualitätssicherung von Daten in Kohortenstudien, am Beispiel des Kompetenznetzes HIV/AIDS Medizin und Gesellschaft Kongress 2007, 17.-21.09.2007, Augsburg, Germany

Mueck B; Balogh AM; Wolf E; Koegl C; Jaegel-Guedes E; Jaeger H. Berufstätigkeit und Bildungsniveau bei HIV-infizierten Frauen und Männern in Deutschland. Deutsch-Oesterreichischer AIDS-Kongress 2007, 27.-30.06.2007, Frankfurt am Main, Germany, A.45, oral presentation. European Journal of Medical Research; 12 (Suppl II):42-3

Müller S; Schätz B; Eismann K; Bergmann S; Walter H; Schmidt B; Korn K; Spriewald B; Schmucker M; Harrer EG; Harrer T; German CompetenceNetwork on HIV/AIDS. Analysis of the sequence of HIV-1-protease and the development of drug resistance in the context of HIV-1 protease-specific Tcells. 3. Deutsch-Oesterreichischer AIDS-Kongress 2007, 27.-30.06.2007, Frankfurt am Main, Germany, F.1, oral presentation. European Journal of Medical Research; 12 (Suppl II): 119

Mueller S; Schaetz B, Eismann K; Bergmann S; Walter H; Schmidt B; Korn K; Schmucker M; Harrer E; Harrer T. Protease inhibitor resistance mutations influence recognition of protease by HIV-1-specific CTL. 11th European AIDS Conference / EACS, 24-27 October 2007, Madrid, Spain

Mueller S; Eismann K; Bergmann  S; Walter H; Schmidt B; Korn K; Schmucker M; Harrer E; Harrer T. HLA Class I-restrictedimmune responses anddrugs exert dual selection pressure on HIV-1 protease. 3rd European Congress of Virology, 01.-05.09.07, Nürnberg, Germany

Mueller S; Schaetz B, Eismann K; Bergmann S; Walter H; Schmidt B; Korn K; Schmucker M; Harrer E; Harrer T. Imprint of HLA-C-restricted Immune Responses on HIV-1 Protease in Comparison to HLAA/ B-restricted Responses. 14th Conference on Retroviruses and Opportunistic Infections, 25.-28.02.07, Los Angeles, USA, Poster abstract 400, pp 211

Nattermann J; Vogel M; Berg T; Danta M; Baumgarten A; Mayr C; Bruno R; Tural C; Klausen G; Clotet B; Lutz T; Grünhage F; Rausch M; Nischalke HD; Schewe K; Bienek B; Haerter G; Spengler U; Rockstroh JK; Sauerbruch T; Kompetenznetz HIV/AIDS. Effect of the IL-6C174G gene polymorphism on treatment of acute and chronic hepatitis C in HIV co-infected patients. 3. Deutsch-Oesterreichischer AIDS-Kongress 2007, 27.-30.06.2007, Frankfurt am Main,Germany, C.3, oral presentation. European Journal of Medical Research; 12 (Suppl II): 70

Nolting T; Koutsilieri E; Husstedt I-W; Gregor N; Maschke M; Obermann M; Sopper S; Arendt G; Kompetenznetz HIV/AIDS. Neuropsychologische Defizite und zentralnerv Oese Zytokinspiegel bei HIV-Patienten. 3. Deutsch-Oesterreichischer AIDS-Kongress 2007, 27.-30.06.2007, Frankfurt am Main, Germany, B.17, Poster. European Journal of Medical Research; 12. (Suppl II): 58

Poggensee G; Kücherer C; Werning J; Bartmeyer B; Fleischhauer C; Braun Ü; Cordes C; Jessen H; Klausen G; Schewe K; Stoll M; Lunzern; J van; Hamouda O. Antiretroviral therapy of patients infected with drug-resistant HIVstrains. Analysis of the composition of the first-line regimen inpatients with a documented date of Hiv- Infection in Germany. 3. Deutsch-Oesterreichischer AIDS-Kongress 2007, 27.-30.06.2007, Frankfurt am Main, Germany, D.68, oral presentation. European Journal of Medical Research; 12 (Suppl II): 106

Potthof A; Brockmeyer NH; Kompetenznetz HIV/AIDS. Massive repeatable hyperlipidemia after switch from lopinavir to boostered fosamprenavir respectively boostered atazanavir 3. Deutsch-Oesterreichischer AIDS-Kongress 2007, 27.-30.06.2007, Frankfurt am Main, Germany, D.59, Poster. European Journal of Medical Research; 12 (Suppl II):102

Potthoff A; Tigges C; Doerler M; Brockmeyer NH; Kompetenznetz HIV/AIDS. Allergic diathesis in HIVinfection. 3. Deutsch-Oesterreichischer AIDS-Kongress 2007, 27.-30.06.2007, Frankfurt am Main, Germany, B.22, Poster. European Journal of Medical Research; 12. (Suppl II): 60

Potthoff A; Brockmeyer N.H.; Tigges C. Allergic diathesis in HIV 4th IAS Conference on Pathogenesis, Treatment and Prevention, Sydney, 22-25 July 2007

Rockstroh-JK; Vogel-M; Bergmann-U; Skaletz-Rorowski-A; Wolf-E; Schenk-Westkamp-P; de Paulo-Bueno-JM; Esser-S; G Oelz-J; Skoetz-N; Jäger-H; Brockmeyer N für das Kompetenz-Netz HIV/AIDS. HIV und Hepatitis Koinfektion in Deutschland: werden koinfizierte Patienten unterschiedlich behandelt? 3. Deutsch-Oesterreichischer AIDS-Kongress 2007, 27.-30.06.2007, Frankfurt am Main, Germany, C.19, Poster. European Journal of Medical Research; 12 (Suppl II): 77

Rockstroh JK; Vogel M; Hahn M; Bergmann U; Skaletz-Rorowski A; Wolf E; Schenk- Westkamp P; de Paulo Bueno JM; Esser S; Gölz J; Skoetz N; Jäger H; Brockmeyer N for the German Competence Network. HIV and Hepatitis co-infection – how is access to HAART in coinfected patients in Germany? 11th European AIDS Conference / EACS, 24-27 October 2007, Madrid, Spain

Rockstroh J; et al. Guidelines for the clinical management and treatment of chronic Hepatitis B and C co-infection in HIV-infected adults (EACS) presented for the first time at the European AIDS Conference in Madrid October 2007, 11th European AIDS Conference / EACS, 24-27 October 2007, Madrid, Spain

Schranz D; Brockmeyer NH; Fischer K; Petrey R; Hower M. Improvements in self-reported gastrointestinal tolerability, Quality of Life (QoL) and therapy preference with lopinavir/ritonavir/ (LPV/r) after switching from BID soft-gel capsule (SGC) to BID tablets (TAB). 3. Deutsch-Oesterreichischer AIDS-Kongress 2007, 27.-30.06.2007, Frankfurt am Main, Germany, D.11, Poster. European Journal of Medical Research; 12. (Suppl II): 83

Schwarze-Zander C; Skoetz N; Kupfer B; Stellbrink HJ; Schmidt RE; Karwat M; Jäger H; Brockmeyer NH; Rockstroh JK for the Competence Network for HIV/AIDS. Prevalence and characteristics of HIV-2 infection in Germany. 3. Deutsch-Oesterreichischer AIDS-Kongress 2007, 27.-30.06.2007, Frankfurt am Main, Germany, B.38, Poster. European Journal of Medical Research; 12 (Suppl II): 67

Skaletz-Rorowski A; Brockmeyer NH; Taubert S; Schwager M. Kooperation zwischen Forschung. und Selbsthilfe im Kompetenznetz HIV/AIDS (Cooperation between research and self-help within the Competence network HIV/AIDS) 6. Deutscher Kongress für Versorgungsforschung / 2. Nationalen Präventionskongress in Dresden (6. German Conference on Health Services Research, 2. National Conference on Prevention, Dresden), 25.10. 2007, Dresden

Skoetz N, Bermgann U, Deneke S Michalik C, Theisen D, Wiegelmann S, Paulus U, Competence Network for HIV/AIDS Patient cohort – Clinical relevance. Deutsch-Oesterreichischer AIDS-Kongress 2007, 27.-30.06.2007, Frankfurt am Main, Germany, D.ER.2, oral presentation invited. European Journal of Medical Research; 12 (Suppl II): 18-19

Skoetz N; Michalik C; Bergmann U; Wiegelmann S; HahnM; Paulus U; Kompetenznetz HIV/AIDS. Auswertungen eines Patientenregisters am Beispiel des Kompetenznetzes HIV/AIDS. Herausforderungen und Loesungsansätze Medizin und Gesellschaft Kongress 2007, 17.-21.09.2007, Augsburg, Germany

Sopper S. Neuroscience in the network of competence HIV/AIDS. 80. Kongress der Deutschen Gesellschaft für Neurologie; 12.-15.9. 07, Berlin, Germany

Stankov M; Schmidt R; Behrens G; German Competence Network HIV/AIDS. Lipoatrophy and ubiquitous mtDNA depletion in mice following long-term stavudine treatment. 14th Conference on Retroviruses and Opportunistic Infections, 25.-28.02.07, Los Angeles, USA, Poster abstract 801, pp 372.Young Investigator Award for first author

Stoll M; Bogner JR; Salzberger B; Stellbrink HJ; Kasnag C; Brockmeyer NH; Michalik C; Ulmer A.; Kompetenznetz HIV/AIDS. The observation of CD 4+ T cell stabilization by long term application of low dose prednisolone needs verification in a prospective and controlled clinical trial CF18, Poster. European Journal of Medical Research; 12 (SupplII):126

Taubert S. Ein Freund, ein guter Freund? Neue Voraussetzungen im Arzt-Patienten-Verhältnis. (A friend, a good friend? New conditions in the doctor-patient relationship). HIV im Dialog, 01.09.2007, Berlin, Germany

Taubert S. Datenschutz und Patientenrechte im Kompetenznetz HIV/AIDS (Privacy and Patients rights within the competence network cohort.) HIV im Dialog, 31.08.2007, Berlin

Venhoff N; Venhoff AC; Jayewardene AL; Aweeka F; Lebrecht D; Walker UA. Pharmacokinetics of Zidovudine and Lamivudine under Oral Uridine Supplementation with NucleomaxX. 11th European AIDS Conference / EACS, 24-27 October 2007, Madrid, Spain, Abstract No. P4.1/12

Verheyen J; Hamouda O; Somogy S; Schuldenzucker U; Poggensee G; Litau E; Pfister H; Hoffmann D; Kaiser R and Kücherer C. Increase of cleavage site mutations in the German HIV-1 seroconverter study over time XVIth International HIV Drug Resistance Workshop, 12-16 Juni 2007, Barbados, Westindien

Verheyen J; Claudia Kuecherer; Elena Litau; Martin Däumer;Marc Oette; Ulrike Schuldenzucker; Daniel Hoffmann; Herbert Pfister; Rolf Kaiser. Cleavage site mutations in transmitted primary resistant HIV of therapy-naïve patients. 5th European HIV drug resistance workshop 28-30.03.2007, Cascais, Portugal

Wagner R; Jens Wild; Kurt Bieler; Hans Wolf; Petra Mooij; Jonathan Heeney; Jonathan Weber; Alexandre Harrari; Guiseppe Pantaleo. Development and Immunogenicity of RNA- and Codon- Optimized HIV Candidate Vaccines in Phase I Clinical Trials. 3. Deutsch-Oesterreichischer AIDS-Kongress 2007, 27.-30.06.2007, Frankfurt am Main, Germany, poster. European Journal of Medical Research; 12 (Suppl II): 126

Wagner R; Kurt Bieler; J Wild; Hans Wolf; Petra Mooij; Jonathan Heeney; Jonathan Weber; Alexandre Harrari; Guiseppe Pantaleo. Impact of RNA- and Codon-Optimization on Safety, Immunogenicity and Efficacy of HIV Candidate Vaccines. AIDS Vaccine Conference, Seattle, USA, 2007

Wagner R; J Wild; Kurt Bieler; Hans Wolf1 Petra Mooij; Jonathan Heeney; Jonathan Weber; Alexandre Harrari; Guiseppe Pantaleo. Development and Immunogenicity of RNA- and Codon-Optimized HIV Candidate Vaccines in Phase I Clinical Trials ESGT Conference Rotterdamm, 2007

Wagner R. Progress in displaying and selecting. HIV envelopes and deriva- tives thereof, CAVD (Consortium AIDS Vaccine Development, Bill & Melinda Gates Foundation). Lausanne, Plenary Session, 2007

Wagner R; J Wild; Kurt Bieler; Hans Wolf; Petra Mooij; Jonathan Heeney; Jonathan Weber; Alexandre Harrari; Guiseppe Pantaleo. Development and Immunogenicity of RNA  and Codon-Optimized HIV Candidate Vaccines in Phase I Clinical Trials. DNA Vaccines Malaga, Plenary Lecture, 2007

Wanninger V; Kurt Bieler; Frank Notka; Markus Graf; Jens Wild; Simon Jeffs; Ralf Wagner. C-terminal fusion of a triple-C3d coding sequence motif reduces expression and immunogenicity of a RNA- and codon optimized Env-gp120 DNA vaccine. 3. Deutsch-Oesterreichischer AIDS-Kongress 2007, 27.- 30.06.2007, Frankfurt am Main, Germany, poster. European Journal of Medical Research; 12 (Suppl II): 121

Wieland U; Pfister H; Hochdorfer B; Brockmeyer NH; Altmeyer P; Kreuter A. A new HPV-associated syndrome with disseminated warts, depressed cell-mediated immunity, primary lymphedema, and widespread genitoanal dysplasia. 4th International HPV and Skin. Cancer Meeting, 27.-30.06.2007, Besancon, France

Wieland U; Brockmeyer NH; Pfister H; Kreuter A. HPV and Anal Cancer. The 23rd IUSTI (International Union against Sexually Transmitted Infections) . Europe Conference on Sexually Transmitted Infections and HIV/AIDS, 13.10.2007, Cavtat/Dubrovnik, Croatia

Wild J; Kurt Bieler; Hans Wolf; R Wagner. Safety and Immunogenicity Assessment of a C-GMP-HIV-1 vaccine preparation in Balb/C Mice. DNA Vaccines Malaga, 2007

Wyen C.; Hendra H.; Groneuer C.; Vogel M.; Hoffmann C.; Knechten H.; Brockmeyer N.; Bogner J.; Rockstroh J.; Esser S.; Skoetz N.; Jetter A.; Fätkenheuer G.; Khoo S. H.; Egan D.; Back D.; Owen A. and the German Competence Network for HIV/AIDS. Cytochrome P450 2B6 (CYP2B6) T983C homozygosity and influence upon NNRTI plasma concentrations in HIVinfected patients. P4.4/01. 11th European AIDS Conference / EACS, 24-27 October 2007, Madrid, Spain

Zeitz M. HIV induced immunodeficiency: A primarily mucosal immunemediated disease. 13th ICMI, Tokyo, Japan, July 9-12, 2007. Program & Abstracts, Keynote Lecture (KL4), pp120

zurück zur Übersicht zurück zur Übersicht

Abstracts 2006

Behrens GMN, Moebius U, Gurjanov A, Mischak H, Schmidt RE, Wittke S. Urinary proteome analysis by capillary electrophroesis coupled mass spectrometry (CE-MS) for detection of tenofovir-associated kidney damage in HIV patients. Antivir Ther 2006; 11:L14 [abstract]

Bode H., H. Schulbin, K. Arastéh, C. Loddenkemper, M. Zeitz, R. Ullrich, for the Kompetenznetz HIV/AIDS. Cytokine mRNA expression in the gut of HIV-infected patients before and after nine months of HAART A18; TUPE 0031; XVI International AIDS Conference; 13-18 August 2006; Toronto, Canada.

Bredl S., Wiesel M., Deml L., Wild J. and Wagner R. Activation of Innate Immune Responses by Human Immunodeficiency Virus Type-1 (HIV-1) Pr55gag Virus-Like Particles (VLP). AIDS Vaccine Conference Amsterdam, 2006

Gurjanov A, Gerschmann S, Lubach-Ruitmann M, Stoll M, Schmidt RE, Behrens GMN. Time until change of first-line antiretroviral therapy in patients receiving NNRTI and protease inhibitor (PI)-containing regimens. Antivir Ther 2006 [abstract]. IF: 5.286

Köstler, J., Hofmann H., Boeckl K., Tischer K., Osterrieder N., Wild J. and Wagner R. Designed New Vaccines Like the Equine Herpesvirus (EHV) Type 1 Based Viral Vectors Effectively Transduces and Activates Monocyte Derived Dendritic Cells. (MDDC), Jahrestagung der deutschen Gesellschaft für Gentherapie, Düsseldorf, 2006

Kücherer C, Poggensee C, Korn K, Werning J, Somogyi S and Hamouda O for the German competence net HIV/AIDS. High level of resistant HIV-1 in newly diagnosed patients both with documented seroconversion and with unknown date of infection. 4th European HIV Drug resistance workshop, 29-31 March 2006, Monte Carlo, France; Poster 10

Kücherer C, Poggensee G, Somogyi S, Werning J, Duwe S, Bienek B, Dupke S, Jessen H, Klausen G, and Hamouda O for the German competence net HIV/AIDS. High level of transmission and persistence of drug resistant HIV-1 in newly infected men who have sex with men in Berlin from 1996 to 2004. Annual Meeting of the GfV 2006, March 15-18,  Munich, Germany

Kücherer C, Poggensee G, Hamouda O für das Kompetenznetz HIV/AIDS. Bedeutung der Übertragung resistenter HIV für den Infektionsverlauf und den Behandlungserfolg – Daten aus der deutschen Serokonverterstudie. DVV/GfV Jahrestagung, 29-30 September, Homburg, Germany

Lankisch T, Moebius U, Wehmeier M, Behrens G, Manns MP, Schmidt RE, Strassburg CP. Gilbert’s disease and atazanavir: From phenotype to UDP-glucuronyltransferase haplotype. 57th Annual Meeting of the American Association for the Study of Liver Diseases, Boston, 27.-31.10.06, Hepatology; 44 (suppl 1): 210A [abstract]; IF: 9.792

Lankisch T, Moebius U, Wehmeier M, Behrens G, Manns MP, Schmidt RE, Strassburg CP. Involvement of uridine diphosphate glucuronosyltransferase (UGT) polymorphisms in atazanavir toxicity. 7th International Workshop on Clinical Pharmacology of HIV Therapy; Lisbon; April 2006. Abstract 30

Muller S., Schatz B., Eismann K., Bergmann S., Bauerle M., Walter H., Schmidt B., Korn K., Spriewald B., Harrer E., Harrer T. Analysis of the influence of HIV-1 protease-specific T-cells on the sequence of HIV-1-protease and the development of drug resistance. 8th International Congress on Drug Therapy in HIV Infection, 12-16 November 2006, Glasgow, UK

Neuen-Jacob E; Vosswinkel D; Koutsilieri E; Sopper S; Müller J; Stahl-Hennig C; Riederer P; terMeulen V for the German Competence Network HIV/AIDS. Differential expression of excitatory amino acid transporters in relation to dopaminergic treatment and SIV specific pathoogy. 79. Kongress der Deutschen Gesellschaft für Neurologie im Rahmen der Super-Neurowoche. Mannheim, 20.-24.9.2006

Poggensee G, Werning J, Kücherer C, Somogyi S, Heiken H, Hower M, Knechten H, Potthoff A, Hamouda O. Analysis of the spatial-temporal occurrence of transmission of resistant HIV in Germany. 4th European HIV Drug resistance workshop, 29-31 March 2006, Monte Carlo, France; Poster 14

Schulbin H. Effects of HAART on the gut mucosal immune system in HIV-infected patients. 2006, Berlin: Freie Universität Berlin

Sing T, Tschochner M, Weisser H, Verheyen J, Daumer M, Kaiser R, Korn K, Walter H, Lengauer T. Predictive and interpretable models relating HIV-1 gag/pol genotype to replication capacity. 4th European HIV Drug Resistance Workshop, Monaco, Monte Carlo, 2006 March 29-31, abstract 55

Skoetz N, Esser S, Bratke T, Wiegelmann S, Jaeger H, Goelz J, Plettenberg A, Fätkenheuer G, Rockstroh J, Brockmeyer NH, Kompetenznetz HIV/AIDS. Clinical-epidemiological characteristics and the impact of gender: results from the German KompNet HIV/AIDS cohort study. Poster – IAS Conference Abstract XVI International AIDS Conference, August 2006, Toronto, Canada

Stankov M, Lücke T, Das A, Schmidt RE, Behrens GMN. Nucleoside reverse transcriptase inhibitors in murine and human adipocytes: impact on mitochondrial DNA depletion and respiratory chain acitivity. Antivir Ther 2006 [abstract]

Stellbrink H.J., Tenner-Racz K., van Lunzen J., Zöllner B., Racz R. Distribution of viral antigen deposits and productively infected cells in lymphoid tissue in different stages of HIV seroconversion and in chronic infection. 8th International Congress on Drug Therapy in HIV Infection, 12-16 November 2006, Glasgow, UK

Sternfeld,T, A Klose, M Schmid, H Demmelmair, B Koletzko, J Bogner, F D Goebel. Hepatic mitochondrial function in HIV infected patients with chronic hepatitis analysed using 13C-methionine breath test. CONVIR, v. 2006, p. Abstract

Stocker H, Sopper S, Weber C, Walter H, Arasteh K. Kompetenznetz HIV/AIDS Deutschland. The effects of protease inhibitors and nucleoside reverse transcriptase inhibitors on the immune system. Int Conf AIDS. Toronto, Canada, 2006 Jul 11-16

Tschochner M, Weber C, Stocker H, Sopper S, Kurowski M, Arasteh K, KompNet HIV/AIDS Germany, Walter H. Changes of HIV-1 Viral Load are Accompanied by Changes in the Numbers of Mutations in Viral Minority Populations. 18. Annual ASHM Conference in Melbourne, Australia, 2006, abstract 493

Tschochner M, Kaiser R, Verheyen J, Daeumer M, Sing T, Weisser H, Lengauer T, Walter H. Influence of HIV-1 resistance associated mutations in gag, protease and reverse transcriptase genes on replicative capacity. 18. Annual ASHM Conference in Melbourne, Australia, 2006 abstract 492

Tschochner M, Weber C, Stocker H, Sopper S, Kurowski M, Walter H, Metzner K, Arasteh K, for the KompNet HIV/AIDS. Small increases of HIV viral load under non-suppressive ART - association with increasing numbers of mutations in viral minority populations. 3. European HIV Drug Resistance Workshop in Athens 2006, abstract 7.2

Tschochner M, Wittmann S, Thein C, Paatz C, Sing T, Weisser H, Lengauer T, Walter H. Use of Support Vector Machines for Identification and Ranking of HIV-1 Mutations in the Protease and Reverse Transcriptase Genes Associated with Changes in Replicative Capacity. Jahrestagung der Gesellschaft für Virologie in München, abstract 254

Wiesel M., Bredl S., Wild J., Speth C., Deml L. and Wagner R. Activation of Innate Immune Responses by Human Immunodeficiency Virus Type-1 (HIV-1) Pr55gag Virus-Like Particles (VLP). Frühjahrstagung der Gesellschaft für Virologie GFV, München, 2006

zurück zur Übersicht zurück zur Übersicht

Abstracts 2005

Arasteh K, Gölz J, Marcus U, Rockstroh J, Salzberger B, Vielhaber B. German-Austrian Recommendations for antiretroviral therapy of HIV-infection – partial (current as of December 2004). Update June 2005 [German]. Published at http://www.daignet.de/

Bieler K., Pitzschler L., Wild J. and Wagner R. Generation of Sequence-Modified Human Immunodeficiency Virus Type 1  GagPolNef DNA Vaccines. Aids Vaccine Montreal 2005

Hofmann, H., Köstler, J., Wild, J., von Einem, J., Trapp, S., Osterrieder, N., Wagner, R. Recombinant Equine Herpesvirus (EHV) Type 1 – A New Viral Vector System that Induces Systemic and Mucosal HIV-Specific Immune Responses. Deutsch-Österreichischer AIDS-Kongress, Wien 2005

Hofmann, H., Köstler, J., Wild, J., von Einem, J., Trapp, S., Osterrieder, N., Wagner, R. Recombinant Equine Herpesvirus (EHV) Type 1 – A New Viral Vector System that Induces Systemic and Mucosal HIV-Specific Immune Responses. Jahrestagung der Gesellschaft für Virologie, Hannover 2005

Kollan C, Stoll M, Kühne A, Matysiak-Klose D, Puscher J, Hamouda O. Changes within the most currently used regimens of antiretroviral treatment (ART) in the German ClinSurv multicenter cohort [Abstract]. Eur J Med Res 06/2005; 10 (Suppl II):70. IF: 0.994. IF: 06/2005

Köstler, J., Wolf, H., Salzberger, B. and Wagner, R. Development and Improvement of Standard Operating Procedures (SOPs) for Monitoring of Virus Specific T-Cells.  Frühjahrstagung der Gesellschaft für Virologie GfV, Hannover, 2005

Kruse G, Königs C, Stumpf S, et al. Intracellular NRTI-triphosphate levels of 3TC, ddI, d4T, CBV, TDF and FTC in HIV-infected children. 6th International Workshop on Clinical Pharmacology of HIV Therapy. Québec, Canada, Apr 28-30

Kunz A, Karcher H, Mayer A, et al. Nevirapine concentration in cervico-vaginal and oropharyngeal secretions in a mother-child cohort in Uganda. IAS Conf HIV Pathog Treat. Rio de Janeiro, Brazil, 2005 Jul 24-27

Schmid,H, D Mühlbayer, J R Bogner, F-D Goebel. Macroenzyme creatine kinase type 2 accumulation in sera of HIV- infected patients: significant association with Tenofovir DF (TDF) treatment. 12th Conference on Retroviruses and opportunistic Infections (CROI), 2005, Boston, USA , Abstract Poster 827. 2006a

Stankov M, Schmidt RE, Behrens GMN. Zidovudine inhibits adipogenic differentiation of 3T3-L1 cells through inhibition of clonal expansion. Antivir Ther 2005; 10:L20. Abstract. IF: 5.286

Stocker H, Kruse G, Weber C, et al. Intracellular concentrations of 3TC-triphosphate, Carbovir-triphosphate and Tenofovir-diphosphate remain stable throughout 36 weeks of NRTI treatment interrupted by NRTI free treatment periods in patients with multiresistant HIV. IAS Conf HIV Pathog Treat. Rio de Janeiro, Brazil, 2005 Jul 24-27

Stocker H, Breske A, Kruse G, et al. Concentrations of Enfuvirtide do not Correlate with Concentrations of Concomitant Protease Inhibitors in Human Immunodeficiency Virus Infected Patients. IAS Conf HIV Pathog Treat. Rio de Janeiro, 2005 Jul 24-27

Stocker H, Kruse G, Breske A, et al. Validierung einer Methode zur Bestimmung von Serum Enfuvirtide Konzentrationen und Definition von Erwartungswerten im Verlauf des Dosierungsintervalls. 10. Deutscher und 16. Österreichischer AIDS Kongress. Vienna, Austria, 2005 Jun 1-4

Stocker H, Breske A, Kruse G, et al. Concentrations of Enfuvirtide do not correlate with concentrations of concomitant protease inhibitors in human immunodeficiency virus infected patients. 10. Deutscher und 16. Österreichischer AIDS Kongress. Vienna, Austria, 2005 Jun 1-4

Tschochner M, Weber C, Stocker H, Sopper S, Kurowski M, Walter H*, Metzner K, Arasteh K, for the KompNet HIV/AIDS. Größere Anzahl an Mutationen in den Subpopulationen während transienter Anstiege der HIV-1 Viruslast unter nicht suppressiver Therapie. 10. Deutscher und 16. Österreichischer AIDS Kongress in Wien 2005

Tschochner M, Weber C, Stocker H, Sopper S, Kurowski M, Walter H*, Metzner K, Arasteh K, for the KompNet HIV/AIDS. Increasing numbers of mutations found in viral minority populations are associated with small increases of HIV viral load under non-suppressive antiretroviral treatment. The 3rd IAS Conference on HIV pathogenesis and Treatment (IAS 2005) in Rio de Janeiro 2005

Tschochner M, Weber C, Stocker H, Sopper S, Kurowski M, Walter H, Arasteh K, for the KompNet HIV/AIDS. Small Differences of HIV-1 Phenotypic Drug Resistance and Viral Replication Capacity in Follow-up Samples Indicate Changes in Viral Minorities Undetected by Conventional Sequencing. Jahrestagung der Gesellschaft für Virologie in Hannover 2005, abstract CLV 28

Wagner, R., Bieler, K., Wolf, H., Ball, S., Heeney, J. Comparative Immunogenicity Testing of GMP Grade HIV-1 Clade C DANN- and Poxvector-Based Candidate Vaccines encoding GagPolNef/Env in Nonhuman Primates. Deutsch-Österreichischer AIDS-Kongress, Wien 2005

Wagner, R., Moji, P., Wild, J., Bieler, K., Wolf, H., Notka, F., Pantaleo, G., Heeney, J. HIV-Vaccines: Novel Strategies to Improve Safety and Efficacy. American Society of Gene Therapy (ASGT) Conference, St. Louis, USA, 2005

Weber C, Stocker H, Tschochner M, Walter H, Arasteh K. CAT Pilotstudie:CD4> 150/µl zu BL ist mit leichtem Anstieg der CD4-Zellen bei stabiler VL assoziiert. 10. Deutscher und 16. Österreichischer AIDS Kongress. Vienna, Austria, 2005 Jun 1-4

Wild., J., Bieler, K., Deml, L., Notka, F., Wolf, H., Wagner, R. Evaluation of GMP Grade HIV-1 Clade C CN54 DNA Vaccines for Human Phase I Trials in a Balb/c Mouse Model. Jahrestagung der Gesellschaft für Virologie, Hannover, 2005

Wild., J., Bieler, K., Deml, L., Notka, F., Wolf, H., Frachette, M.-J., Wagner, R. Evaluation of GMP Grade HIV-1 Clade C CN54 DNA Vaccines for Human Phase I Trials in a Balb/c Mouse Model. Deutsch-Österreichischer AIDS-Kongress, Wien, 2005

zurück zur Übersicht zurück zur Übersicht

Publikationsrichtlinien des Kompetenznetzes HIV/AIDS

Publikationsrichtlinien für Veröffentlichungen mit Beteiligung des Kompetenznetzes HIV/AIDS

Für eine gute Sichtbarkeit in der Öffentlichkeit ist die Nennung des Kompetenznetzes HIV/AIDS in Publikationen inklusive Abstracts und Postern wichtig. Falls Sie eine Veröffentlichung mit Beteiligung des Kompetenznetzes HIV/AIDS submittieren, bitten wir Sie, das KompNet wie folgt nach den Vorgaben des DLR´s zu nennen:

bei klinisch-epidemiologischen Studien (multizentrisch):
....Autor und das Kompetenznetz HIV/AIDS
....author and the Competence Network for HIV/AIDS (in englischer Sprache)

bei Grundlagenforschung und monozentrischen Studien:
....Autor für das Kompetenznetz HIV/AIDS
....author for the Competence Network for HIV/AIDS (in englischer Sprache)

Bitte beachten Sie auch die weiteren generellen Vorgaben des Kompetenznetzes HIV/AIDS zur Autorenschaft:

Nach Empfehlung der SOP-Gruppe vom 13.05.2005 ist eine Gesamtautorenzahl von 10 anzustreben. Als Erstautor sollte der Principal Investigator genannt werden, der die Idee für die Auswertung gegeben und die entsprechende Arbeit angefertigt hat, sowie 2-3 Mitarbeiter, die sich um die Datenauswertung seitens der Koordinierungsstelle sowie der KKSK und /oder Statistik gekümmert haben. Bei der Autorenschaft sollten die Zentren berücksichtigt werden, die die meisten Daten zu Ihren Abstrakts oder Publikationen eingegeben haben. Es sind 6 Koautoren vorgesehen, die sich nach eingebrachter Datenmenge, Datenqualität und regionalen Aspekten rekrutieren. Hierbei sollte Wert darauf gelegt werden, dass auch kleinere Zentren entsprechend bei der Dokumentation auf Dauer berücksichtigt werden. Im Anhang sollten alle Zentren jeweils aufgeführt werden. Um diese Zentren zu bestimmen, sollten Sie sich mit dem KKSK in Verbindung setzen. Planen Sie hierfür bitte ein paar Tage Zeit ein, dies beim KKSK zu ermitteln.

Als Download erhalten Sie die Publikationsrichtlinien hier als PDF-Datei (51 KB).

zurück zur Übersicht zurück zur Übersicht


Seite erstellt am 09.02.2009
Letzte Aktualisierung am 19.12.2013

Top Top